CATH Search:   
       by CATH code, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Mainly Alpha (13335)
(-)
Architecture: Orthogonal Bundle (10391)
(-)
Topology: Transferase(Phosphotransferase); domain 1 (1379)
(-)
Homologous Superfamily: Transferase(Phosphotransferase) domain 1 (1379)
(-)
[unclassified] (4)
1GY3A:85-295; C:85-295PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE
2BZKB:125-305CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AMPPNP AND PIMTIDE
2C3IB:125-305CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH IMIDAZOPYRIDAZIN I
2WNTA:455-473,A:492-708; B:454-473,B:492-709CRYSTAL STRUCTURE OF THE HUMAN RIBOSOMAL PROTEIN S6 KINASE
(-)
African clawed frog (Xenopus laevis) (3)
2VGOA:174-347; B:177-346CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH REVERSINE INHIBITOR
2VGPA:174-347; B:177-346CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH A AMINOTHIAZOLE INHIBITOR
2VRXA:174-347; B:177-346STRUCTURE OF AURORA B KINASE IN COMPLEX WITH ZM447439
(-)
Baker's yeast (Saccharomyces cerevisiae) (21)
1FOTA:171-361STRUCTURE OF THE UNLIGANDED CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT FROM SACCHAROMYCES CEREVISIAE
1HOWA:212-225,A:249-737THE X-RAY CRYSTAL STRUCTURE OF SKY1P, AN SR PROTEIN KINASE IN YEAST
1Q8YA:212-225,A:249-735; B:212-225,B:249-735THE STRUCTURE OF THE YEAST SR PROTEIN KINASE, SKY1P, WITH BOUND ADP
1Q8ZA:212-225,A:249-735; B:212-225,B:249-735THE APOENZYME STRUCTURE OF THE YEAST SR PROTEIN KINASE, SKY1P
1Q97A:212-225,A:249-735; B:212-225,B:249-735THE STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SR PROTEIN KINASE, SKY1P, WITH BOUND ATP
1Q99A:212-225,A:249-735; B:212-225,B:249-735CRYSTAL STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SR PROTEIN KINSAE, SKY1P, COMPLEXED WITH THE NON-HYDROLYZABLE ATP ANALOGUE, AMP-PNP
2A19B:369-541; C:372-541PKR KINASE DOMAIN- EIF2ALPHA- AMP-PNP COMPLEX.
2A1AB:369-541PKR KINASE DOMAIN-EIF2ALPHA COMPLEX
2B9FA:96-338CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FUS3
2B9HA:96-338CRYSTAL STRUCTURE OF FUS3 WITH A DOCKING MOTIF FROM STE7
2B9IA:96-338CRYSTAL STRUCTURE OF FUS3 WITH A DOCKING MOTIF FROM MSG5
2B9JA:96-338CRYSTAL STRUCTURE OF FUS3 WITH A DOCKING MOTIF FROM FAR1
2F49A:96-338; B:96-338CRYSTAL STRUCTURE OF FUS3 IN COMPLEX WITH A STE5 PEPTIDE
2F9GA:96-338CRYSTAL STRUCTURE OF FUS3 PHOSPHORYLATED ON TYR182
2FA2A:96-338; B:96-338CRYSTAL STRUCTURE OF FUS3 WITHOUT A PEPTIDE FROM STE5
2FH9A:135-319STRUCTURE AND DIMERIZATION OF THE KINASE DOMAIN FROM YEAST SNF1
2JD5A:212-225,A:249-738; B:212-225,B:249-737SKY1P BOUND TO NPL3P-DERIVED SUBSTRATE PEPTIDE
2PK9C:87-300; A:87-301STRUCTURE OF THE PHO85-PHO80 CDK-CYCLIN COMPLEX OF THE PHOSPHATE-RESPONSIVE SIGNAL TRANSDUCTION PATHWAY
2PMIC:87-301; A:87-302STRUCTURE OF THE PHO85-PHO80 CDK-CYCLIN COMPLEX OF THE PHOSPHATE-RESPONSIVE SIGNAL TRANSDUCTION PATHWAY WITH BOUND ATP-GAMMA-S
3DAEA:135-315; B:135-315CRYSTAL STRUCTURE OF PHOSPHORYLATED SNF1 KINASE DOMAIN
(-)
Bantam,chickens (Gallus gallus) (6)
3EN4B:341-526; A:341-526TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH PP121, A MULTITARGETED KINASE INHIBITOR
3EN5B:341-526; A:341-526TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH PP494, A MULTITARGETED KINASE INHIBITOR
3EN6B:341-526; A:341-526TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH PP102, A MULTITARGETED KINASE INHIBITOR
3EN7A:341-526; B:341-526TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH S1, A MULTITARGETED KINASE INHIBITOR
3F6XA:341-526; C:341-526; D:341-526; B:341-526C-SRC KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3GEQB:341-521; A:341-521STRUCTURAL BASIS FOR THE CHEMICAL RESCUE OF SRC KINASE ACTIVITY
(-)
Bos taurus. Organism_taxid: 9913. (2)
2C1AA:15-32,A:127-317STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE
2C1BA:15-32,A:127-317STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH ( 4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE
(-)
Bovine (Bos taurus) (23)
2JDSA:15-32,A:127-317STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A-443654
2JDTA:15-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE
2JDVA:15-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH A-443654
2UVXA:14-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 7-AZAINDOLE
2UVYA:15-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH METHYL-(4-(9H-PURIN-6-YL)-BENZYL)-AMINE
2UVZA:14-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-PHENYL-C-(4-( 9H-PURIN-6-YL)-PHENYL)-METHYLAMINE
2UW0A:14-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 6-(4-(4-(4-CHLORO-PHENYL)-PIPERIDIN-4-YL)-PHENYL)-9H-PURINE
2UW4A:14-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-(5-METHYL-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE
2UW5A:15-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (R)-2-(4-CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE
2UW6A:14-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (S)-2-(4-CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE
2UW7A:14-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4-CHLORO-PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE
2UW8A:14-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-CHLORO-PHENYL)-2-PHENYL-ETHYLAMINE
2UZTA:15-32,A:127-317PKA STRUCTURES OF AKT, INDAZOLE-PYRIDINE INHIBITORS
2UZUE:15-32,E:127-317PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS
2UZVA:15-32,A:127-317PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS
2UZWE:15-32,E:127-317PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS
2VNWA:14-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6-YL)PIPERIDIN-4-YL)METHANAMINE
2VNYA:14-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6-YL)PIPERIDIN-4-YL)AMINE
2VO0A:8-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4-CHLOROPHENYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YL)METHYLAMINE
2VO3A:14-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4-CHLOROPHENYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YL)METHYLAMINE
2VO6A:13-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE
2VO7A:15-32,A:127-317STRUCTURE OF PKA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE
3BWJA:15-32,A:127-317COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR LEAD COMPOUND ARC-1034
(-)
Bovine,cow,domestic cattle,domestic cow (Bos taurus) (2)
3DNDA:15-32,A:127-317CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
3DNEA:13-32,A:127-317CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
(-)
Brewer's yeast,lager beer yeast,yeast (Saccharomyces cerevisiae) (1)
3FAM  [entry was replaced by entry 3HYH without any CATH domain information]
(-)
Brown rat,rat,rats (Rattus norvegicus) (1)
3FPQB:115-293; A:115-292CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF WNK1
(-)
Caenorhabditis elegans. Organism_taxid: 6239. (1)
2BDWA:92-315; B:92-318CRYSTAL STRUCTURE OF THE AUTO-INHIBITED KINASE DOMAIN OF CALCIUM/CALMODULIN ACTIVATED KINASE II
(-)
Caenorhabditis elegans. Organism_taxid: 6239. (1)
1KOAA:6021-6265TWITCHIN KINASE FRAGMENT (C.ELEGANS), AUTOREGULATED PROTEIN KINASE AND IMMUNOGLOBULIN DOMAINS
(-)
California sea hare (Aplysia californica) (1)
1KOBA:132-374; B:132-374TWITCHIN KINASE FRAGMENT (APLYSIA), AUTOREGULATED PROTEIN KINASE DOMAIN
(-)
Cattle (Bos taurus) (42)
1OMWA:276-475CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN G PROTEIN-COUPLED RECEPTOR KINASE 2 AND HETEROTRIMERIC G PROTEIN BETA 1 AND GAMMA 2 SUBUNITS
1Q24A:14-32,A:127-317PKA DOUBLE MUTANT MODEL OF PKB IN COMPLEX WITH MGATP
1Q61A:14-32,A:127-317PKA TRIPLE MUTANT MODEL OF PKB
1Q62A:13-32,A:127-317PKA DOUBLE MUTANT MODEL OF PKB
1Q8TA:15-32,A:127-317THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH RHO-KINASE INHIBITOR Y-27632
1Q8UA:15-32,A:127-317THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH RHO-KINASE INHIBITOR H-1152P
1Q8WA:15-32,A:127-317THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH RHO-KINASE INHIBITOR FASUDIL (HA-1077)
1SMHA:13-32,A:127-317PROTEIN KINASE A VARIANT COMPLEX WITH COMPLETELY ORDERED N-TERMINAL HELIX
1STCE:15-32,E:127-317CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH STAUROSPORINE
1SVEA:15-32,A:127-317CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 1
1SVGA:15-32,A:127-317CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 4
1SVHA:15-32,A:127-317CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 8
1SZMA:15-32,A:127-316; B:14-32,B:127-316DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO PROTEIN KINASE A (PKA)
1VEBA:15-32,A:127-317CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 5
1XH4A:15-32,A:127-317CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1XH5A:15-32,A:127-317CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1XH6A:18-32,A:127-317CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1XH7A:15-32,A:127-317CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1XH8A:15-32,A:127-317CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1XH9A:13-32,A:127-317CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1XHAA:13-32,A:127-317CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1YDRE:15-32,E:127-317STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H7 PROTEIN KINASE INHIBITOR 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE
1YDSE:15-32,E:127-317STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H8 PROTEIN KINASE INHIBITOR [N-(2-METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE
1YDTE:15-32,E:127-317STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KINASE INHIBITOR N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE
2BCJA:276-493CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH GALPHA-Q AND GBETAGAMMA SUBUNITS
2F2UA:176-374; B:176-374CRYSTAL STRUCTURE OF THE RHO-KINASE KINASE DOMAIN
2F7EE:15-32,E:127-317PKA COMPLEXED WITH (S)-2-(1H-INDOL-3-YL)-1-(5-ISOQUINOLIN-6-YL-PYRIDIN-3-YLOXYMETHYL-ETYLAMINE
2F7XE:15-32,E:127-317PROTEIN KINASE A BOUND TO (S)-2-(1H-INDOL-3-YL)-1-[5-((E)-2-PYRIDIN-4-YL-VINYL)-PYRIDIN-3-YLOXYMETHYL]-ETHYLAMINE
2F7ZE:15-32,E:127-317PROTEIN KINASE A BOUND TO (R)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE
2GFCA:15-32,A:127-317CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
2GNFA:15-32,A:127-317PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH Y-27632
2GNGA:15-32,A:127-317PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE
2GNHA:15-32,A:127-317PKA FIVE FOLD MUTANT MODEL OF RHO-KINASE WITH H1152P
2GNIA:15-32,A:127-317PKA FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITOR FASUDIL (HA1077)
2GNJA:15-32,A:127-317PKA THREE FOLD MUTANT MODEL OF RHO-KINASE WITH Y-27632
2GNLA:15-32,A:127-317PKA THREEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITOR H-1152P
2H9VA:176-374STRUCTURAL BASIS FOR INDUCED-FIT BINDING OF RHO-KINASE TO THE INHIBITOR Y27632
2OH0E:15-32,E:127-317CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH PYRIDINE-PYRAZOLOPYRIDINE BASED INHIBITORS
2OJFE:15-32,E:127-317CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH PYRIDINE-PYRAZOLOPYRIDINE BASED INHIBITORS
3C4XA:271-472; B:271-472CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ATP AND MAGNESIUM CHLORIDE AT 2.9A
3C50B:271-472; A:271-475CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ADP AND MAGNESIUM CHLORIDE AT 2.6A
3C51A:271-472; B:271-472CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ADP AND MAGNESIUM CHLORIDE AT 3.55A
(-)
Chicken (Gallus gallus) (24)
2HWOA:341-526; B:341-526CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH COVALENT INHIBITOR
2HWPA:341-526; B:341-526CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH COVALENT INHIBITOR PD168393
2J0LA:502-684CRYSTAL STRUCTURE OF A THE ACTIVE CONFORMATION OF THE KINASE DOMAIN OF FOCAL ADHESION KINASE WITH A PHOSPHORYLATED ACTIVATION LOOP.
2J0MB:502-684CRYSTAL STRUCTURE A TWO-CHAIN COMPLEX BETWEEN THE FERM AND KINASE DOMAINS OF FOCAL ADHESION KINASE.
2JKKA:502-684FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR
2JKMA:502-684FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR
2JKOA:502-684FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR
2JKQA:502-684FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR
2OIQB:341-526; A:341-526CRYSTAL STRUCTURE OF CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH THE CANCER DRUG IMATINIB.
2PTKA:345-519CHICKEN SRC TYROSINE KINASE
2QI8A:341-526; B:341-526CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN
2QLQB:341-526; A:341-526CRYSTAL STRUCTURE OF SRC KINASE DOMAIN WITH COVALENT INHIBITOR RL3
2QQ7A:341-526; B:341-526CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN WITH IRREVERSIBLE INHIBITOR
3DQWA:341-526; B:341-526; C:341-526; D:341-526C-SRC KINASE DOMAIN THR338ILE MUTANT IN COMPLEX WITH ATPGS
3DQXB:341-526; A:341-526CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH ATPGS
3EL7A:341-526CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH PYRAZOLOPYRIMIDINE 3
3EL8A:341-526; B:341-526CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH PYRAZOLOPYRIMIDINE 5
3F3TB:341-526; A:341-526KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL38 (TYPE III)
3F3UA:341-526; B:341-526KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL37 (TYPE III)
3F3VA:341-526; B:341-526KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL45 (TYPE II)
3F3WA:341-526; B:341-526DRUG RESISTANT CSRC KINASE DOMAIN IN COMPLEX WITH INHIBITOR RL45 (TYPE II)
3G5DA:341-526; B:341-526KINASE DOMAIN OF CSRC IN COMPLEX WITH DASATINIB
3G6GA:341-526; B:341-526EQUALLY POTENT INHIBITION OF C-SRC AND ABL BY COMPOUNDS THAT RECOGNIZE INACTIVE KINASE CONFORMATIONS
3G6HA:341-526; B:341-526SRC THR338ILE INHIBITED IN THE DFG-ASP-OUT CONFORMATION
(-)
Cow (Bos taurus) (3)
2UW3A:14-32,A:127-317STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 5-METHYL-4-PHENYL-1H-PYRAZOLE
3E8CA:15-32,A:127-317; D:15-32,D:127-317; E:15-32,E:127-317; F:15-32,F:127-317; B:15-32,B:127-317; C:15-32,C:127-317CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS
3E8EA:15-32,A:127-317; B:15-32,B:127-317; E:15-32,E:127-317; I:15-32,I:127-317; L:15-32,L:127-317; P:15-32,P:127-317CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS
(-)
Cryptosporidium parvum iowa ii. Organism_taxid: 353152. (3)
2WEIA:158-338CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF CRYPTOSPORIDIUM PARVUM CALCIUM DEPENDENT PROTEIN KINASE IN COMPLEX WITH 3-MB-PP1
3EB0A:122-375; C:122-375CRYSTAL STRUCTURE OF CGD4_240 FROM CRYPTOSPORIDIUM PARVUM IN COMPLEX WITH INDIRUBIN E804
3F3ZA:105-294CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM CALCIUM DEPENDENT PROTEIN KINASE CGD7_1840 IN PRESENCE OF INDIRUBIN E804
(-)
Cryptosporidium parvum iowa ii. Organism_taxid: 353152. Strain: iowa ii. (1)
3DFAA:89-267CRYSTAL STRUCTURE OF KINASE DOMAIN OF CALCIUM-DEPENDENT PROTEIN KINASE CGD3_920 FROM CRYPTOSPORIDIUM PARVUM
(-)
Cryptosporidium parvum iowa ii. Organism_taxid: 353152. Strain: iowa ii. (1)
2QG5A:108-287; B:108-287; D:108-286CRYPTOSPORIDIUM PARVUM CALCIUM DEPENDENT PROTEIN KINASE CGD7_1840
(-)
Cryptosporidium parvum iowa ii. Organism_taxid: 353152. Strain: iowa type ii. (1)
2QKRA:103-310CRYPTOSPORIDIUM PARVUM CYCLIN-DEPENDENT KINASE CGD5_2510 WITH INDIRUBIN 3'-MONOXIME BOUND
(-)
Currant tomato (Solanum pimpinellifolium) (1)
3HGKA:119-317; B:119-317; C:119-317; D:119-317CRYSTAL STRUCTURE OF EFFECT PROTEIN AVRPTOB COMPLEXED WITH KINASE PTO
(-)
Fall armyworm (Spodoptera frugiperda) (1)
1UU9A:166-357STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-3
(-)
Fission yeast (Schizosaccharomyces pombe) (3)
1CSNA:88-298BINARY COMPLEX OF CASEIN KINASE-1 WITH MGATP
1EH4A:88-298; B:88-298BINARY COMPLEX OF CASEIN KINASE-1 FROM S. POMBE WITH AN ATP COMPETITIVE INHIBITOR, IC261
2CSNA:88-298BINARY COMPLEX OF CASEIN KINASE-1 WITH CKI7
(-)
Herpesvirus saimiri (Saimiriine herpesvirus 2) (2)
1JOWB:103-299CRYSTAL STRUCTURE OF A COMPLEX OF HUMAN CDK6 AND A VIRAL CYCLIN
1XO2B:103-299CRYSTAL STRUCTURE OF A HUMAN CYCLIN-DEPENDENT KINASE 6 COMPLEX WITH A FLAVONOL INHIBITOR, FISETIN
(-)
Herpesvirus saimiri (strain 11). Organism_taxid: 10383. Strain: 11. (2)
2EUFB:103-299X-RAY STRUCTURE OF HUMAN CDK6-VCYCLIN IN COMPLEX WITH THE INHIBITOR PD0332991
2F2CB:103-299X-RAY STRUCTURE OF HUMAN CDK6-VCYCLINWITH THE INHIBITOR AMINOPURVALANOL
(-)
Homo sapiens (Homo sapiens) (1)
2W1IA:932-1128; B:932-1128STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
(-)
Homo sapiens. (1)
3D0EA:236-429; B:236-429CRYSTAL STRUCTURE OF HUMAN AKT2 IN COMPLEX WITH GSK690693
(-)
Homo sapiens. Organism_taxid: 9606. (16)
3CQEA:356-360,A:380-570WEE1 KINASE COMPLEX WITH INHIBITOR PD074291
3CR0A:356-360,A:380-573WEE1 KINASE COMPLEX WITH INHIBITOR PD259_809
3CXWA:125-306CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A BETA CARBOLINE LIGAND I
3CY2A:125-305CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A BETA CARBOLINE LIGAND II
3CY3A:125-305CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND THE JNK INHIBITOR V
3D83A:111-319CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIPHENYL AMIDE INHIBITOR
3DCVA:125-305CRYSTAL STRUCTURE OF HUMAN PIM1 KINASE COMPLEXED WITH 4-(4-HYDROXY-3-METHYL-PHENYL)-6-PHENYLPYRIMIDIN-2(1H)-ONE
3DU8B:137-355; A:137-382CRYSTAL STRUCTURE OF GSK-3 BETA IN COMPLEX WITH NMS-869553A
3DZQA:703-904HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH INHIBITOR AWL-II-38.3
3E5AA:217-387CRYSTAL STRUCTURE OF AURORA A IN COMPLEX WITH VX-680 AND TPX2
3EFLA:919-1166; B:919-1165CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH MOTESANIB
3EMGA:451-631DISCOVERY AND SAR OF NOVEL 4-THIAZOLYL-2-PHENYLAMINOPYRIMIDINES AS POTENT INHIBITORS OF SPLEEN TYROSINE KINASE (SYK)
3EOCA:85-296; C:85-296CDK2/CYCLINA COMPLEXED WITH A IMIDAZO TRIAZIN-2-AMINE
3EWHA:919-1166CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDYL-PYRIMIDINE BENZIMIDAZOLE INHIBITOR
3F9NA:98-270CRYSTAL STRUCTURE OF CHK1 KINASE IN COMPLEX WITH INHIBITOR 38
3FC1X:111-319CRYSTAL STRUCTURE OF P38 KINASE BOUND TO PYRIMIDO-PYRIDAZINONE INHIBITOR
(-)
Homo sapiens. Organism_taxid: 9606. (9)
1W0XC:85-296CRYSTAL STRUCTURE OF HUMAN CDK2 IN COMPLEX WITH THE INHIBITOR OLOMOUCINE.
2CLQA:758-940; B:758-940STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5
2ITNA:793-1004CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AMP-PNP
2ITOA:793-1004CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH IRESSA
2ITQA:793-984CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AFN941
2ITUA:793-987CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AFN941
2ITYA:793-989CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH IRESSA
2R64A:85-296CRYSTAL STRUCTURE OF A 3-AMINOINDAZOLE COMPOUND WITH CDK2
2WQEA:217-387STRUCTURE OF S155R AURORA-A SOMATIC MUTANT
(-)
Homo sapiens. Organism_taxid: 9606. Cell_line: sf9. (2)
3FAAB:285-501; A:285-500; C:285-500; D:285-500; E:285-500CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A 2-AMINOIMIDAZOLE INHIBITOR
3HRFA:166-357CRYSTAL STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH AN ALLOSTERIC ACTIVATOR BOUND TO THE PIF-POCKET
(-)
House mouse (Mus musculus) (41)
1APME:11-32,E:127-3172.0 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PEPTIDE INHIBITOR AND DETERGENT
1ATPE:15-32,E:127-3172.2 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH MNATP AND A PEPTIDE INHIBITOR
1BKXA:12-32,A:127-317A BINARY COMPLEX OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE AND ADENOSINE FURTHER DEFINES CONFORMATIONAL FLEXIBILITY
1BX6A:12-32,A:127-317CRYSTAL STRUCTURE OF THE POTENT NATURAL PRODUCT INHIBITOR BALANOL IN COMPLEX WITH THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE
1FMOE:13-32,E:127-317CRYSTAL STRUCTURE OF A POLYHISTIDINE-TAGGED RECOMBINANT CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH THE PEPTIDE INHIBITOR PKI(5-24) AND ADENOSINE
1FPUA:318-499; B:318-498CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
1IEPA:318-498; B:318-498CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571.
1J3HB:11-32,B:127-317; A:10-32,A:127-317CRYSTAL STRUCTURE OF APOENZYME CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT
1JBPE:9-32,E:127-317CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A SUBSTRATE PEPTIDE, ADP AND DETERGENT
1JLUE:12-32,E:127-317CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PHOSPHORYLATED SUBSTRATE PEPTIDE AND DETERGENT
1JPAA:710-898; B:710-895CRYSTAL STRUCTURE OF UNPHOSPHORYLATED EPHB2 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION
1L3RE:1-32,E:127-317CRYSTAL STRUCTURE OF A TRANSITION STATE MIMIC OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE
1LEWA:111-319CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A
1LEZA:111-319CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS ACTIVATOR MKK3B
1M52B:318-503; A:318-502CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH PD173955
1OPJA:337-516; B:337-516STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
1OPKA:345-519STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
1P38  [entry was replaced by entry 5UOJ without any CATH domain information]
1RDQE:5-32,E:127-317HYDROLYSIS OF ATP IN THE CRYSTAL OF Y204A MUTANT OF CAMP-DEPENDENT PROTEIN KINASE
1RE8A:12-32,A:127-317CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 2
1REJA:16-32,A:127-317CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 1
1REKA:13-32,A:127-317CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 8
1SYKB:13-32,B:127-317; A:10-32,A:127-322CRYSTAL STRUCTURE OF E230Q MUTANT OF CAMP-DEPENDENT PROTEIN KINASE REVEALS UNEXPECTED APOENZYME CONFORMATION
1YW2A:1111-1319MUTATED MUS MUSCULUS P38 KINASE (MP38)
1YWRA:111-319CRYSTAL STRUCTURE ANALYSIS OF INACTIVE P38 KINASE DOMAIN IN COMPLEX WITH A MONOCYCLIC PYRAZOLONE INHIBITOR
2CPKE:15-32,E:127-317CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CYCLIC ADENOSINE MONOPHOSPHATE-DEPENDENT PROTEIN KINASE
2ERZE:15-32,E:127-317CRYSTAL STRUCTURE OF C-AMP DEPENDENT KINASE (PKA) BOUND TO HYDROXYFASUDIL
2EWAA:111-319DUAL BINDING MODE OF PYRIDINYLIMIDAZOLE TO MAP KINASE P38
2GHLA:111-319MUTANT MUS MUSCULUS P38 KINASE DOMAIN IN COMPLEX WITH INHIBITOR PG-874743
2GHMA:111-319MUTATED MAP KINASE P38 (MUS MUSCULUS) IN COMPLEX WITH INHBITOR PG-895449
2GTMA:111-319MUTATED MOUSE P38 MAP KINASE DOMAIN IN COMPLEX WITH INHIBITOR PG-892579
2GTNA:111-319MUTATED MAP KINASE P38 (MUS MUSCULUS) IN COMPLEX WITH INHBITOR PG-951717
2HELA:702-888CRYSTAL STRUCTURE OF A MUTANT EPHA4 KINASE DOMAIN (Y742A)
2HENA:710-898; B:710-898; C:710-898; D:710-898CRYSTAL STRUCTURE OF THE EPHB2 RECEPTOR KINASE DOMAIN IN COMPLEX WITH ADP
2HZNA:318-497ABL KINASE DOMAIN IN COMPLEX WITH NVP-AFG210
2QCSA:13-32,A:127-317A COMPLEX STRUCTURE BETWEEN THE CATALYTIC AND REGULATORY SUBUNIT OF PROTEIN KINASE A THAT REPRESENTS THE INHIBITED STATE
2QOHA:318-497; B:318-497CRYSTAL STRUCTURE OF ABL KINASE BOUND WITH PPY-A
2QR7A:459-477,A:497-7142.0A X-RAY STRUCTURE OF C-TERMINAL KINASE DOMAIN OF P90 RIBOSOMAL S6 KINASE 2: SE-MET DERIVATIVE
2QR8A:459-477,A:496-7142.0A X-RAY STRUCTURE OF C-TERMINAL KINASE DOMAIN OF P90 RIBOSOMAL S6 KINASE 2 (RSK2)
2QVSE:13-32,E:127-317CRYSTAL STRUCTURE OF TYPE IIA HOLOENZYME OF CAMP-DEPENDENT PROTEIN KINASE
2Z60A:318-497CRYSTAL STRUCTURE OF THE T315I MUTANT OF ABL KINASE BOUND WITH PPY-A
(-)
Human (Homo sapiens) (1049)
1A9UA:111-319THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580
1AD5A:345-519; B:345-519SRC FAMILY KINASE HCK-AMP-PNP COMPLEX
1AGWA:564-759; B:564-756CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU4984 INHIBITOR
1AQ1A:85-296HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR STAUROSPORINE
1B38A:85-297HUMAN CYCLIN-DEPENDENT KINASE 2
1B39A:85-297HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160
1B6CB:285-500; D:285-500; F:285-500; H:285-500CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12
1BI7A:103-299MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE STRUCTURE OF THE CDK6-P16INK4A TUMOR SUPPRESSOR COMPLEX
1BI8A:103-299; C:103-299MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE STRUCTURES CDK6-P19INK4D INHIBITOR COMPLEX
1BL6A:111-319THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995
1BL7A:111-319THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025
1BLXA:103-299P19INK4D/CDK6 COMPLEX
1BMKA:111-319THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655
1BUHA:85-293CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1
1BYGA:269-445KINASE DOMAIN OF HUMAN C-TERMINAL SRC KINASE (CSK) IN COMPLEX WITH INHIBITOR STAUROSPORINE
1CKPA:85-296HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B
1CM8A:114-328; B:1114-1328PHOSPHORYLATED MAP KINASE P38-GAMMA
1DI8A:85-296THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE
1DI9A:111-319THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH 4-[3-METHYLSULFANYLANILINO]-6,7-DIMETHOXYQUINAZOLINE
1DM2A:85-296HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE
1E1VA:85-297HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058
1E1XA:85-297HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027
1E9HA:85-295; C:85-295THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5-SULPHONATE BOUND
1F3MC:347-542; D:347-541CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1
1F5QC:85-294; A:85-297CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDENT KINASE 2
1FGIA:564-759; B:564-757CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU5402 INHIBITOR
1FINA:85-297; C:85-297CYCLIN A-CYCLIN-DEPENDENT KINASE 2 COMPLEX
1FMKA:345-519CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC
1FQ1B:85-295CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) IN COMPLEX WITH PHOSPHO-CDK2
1FVRA:905-1112; B:905-1112TIE2 KINASE DOMAIN
1FVTA:85-296THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH AN OXINDOLE INHIBITOR
1FVVA:85-297; C:85-297THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLE INHIBITOR
1G3NA:103-299; E:103-299STRUCTURE OF A P18(INK4C)-CDK6-K-CYCLIN TERNARY COMPLEX
1G5SA:85-296CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH THE INHIBITOR H717
1GAGA:1079-1281CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR
1GIHA:85-296HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
1GIIA:85-296HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
1GIJA:85-296HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
1GJOA:567-762THE FGFR2 TYROSINE KINASE DOMAIN
1GNGA:137-383; B:137-383GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE
1GZ8A:85-296HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL-2'-OXO)BUTOXYPURINE
1GZKA:236-429MOLECULAR MECHANISM FOR THE REGULATION OF PROTEIN KINASE B/ AKT BY HYDROPHOBIC MOTIF PHOSPHORYLATION
1GZNA:236-429STRUCTURE OF PKB KINASE DOMAIN
1GZOA:236-429STRUCTURE OF PROTEIN KINASE B UNPHOSPHORYLATED
1H00A:85-295CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1H01A:85-294CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1H07A:85-294CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1H08A:85-296CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1H0VA:85-296HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[(R)-PYRROLIDINO-5'-YL]METHOXYPURINE
1H0WA:85-296HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[CYCLOHEX-3-ENYL]METHOXYPURINE
1H1PA:85-295; C:85-295STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058
1H1QA:85-295; C:85-295STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094
1H1RA:85-295; C:85-295STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086
1H1SA:85-295; C:85-295STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102
1H1WA:166-357HIGH RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PDK1 CATALYTIC DOMAIN
1H24A:85-292; C:85-292CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F
1H25C:85-291; A:85-292CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN
1H26C:85-294; A:85-295CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53
1H27C:85-294; A:85-295CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27
1H28A:85-295; C:85-295CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107
1H4LA:85-285; B:85-285STRUCTURE AND REGULATION OF THE CDK5-P25(NCK5A) COMPLEX
1H8FA:137-383; B:137-383GLYCOGEN SYNTHASE KINASE 3 BETA.
1HCKA:85-297HUMAN CYCLIN-DEPENDENT KINASE 2
1HCLA:85-297HUMAN CYCLIN-DEPENDENT KINASE 2
1I09A:137-382; B:137-382STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3B)
1I44A:1079-1282CRYSTALLOGRAPHIC STUDIES OF AN ACTIVATION LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE
1IA8A:98-276THE 1.7 A CRYSTAL STRUCTURE OF HUMAN CELL CYCLE CHECKPOINT KINASE CHK1
1IASB:285-500; A:285-500; C:285-500; D:285-500; E:285-500CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12
1IG1A:106-2911.8A X-RAY STRUCTURE OF TERNARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE AND MN.
1IR3A:1079-1281PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOG
1IRKA:1079-1283CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HUMAN INSULIN RECEPTOR
1J1BB:637-882; A:137-383BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH AMPPNP
1J1CB:637-882; A:137-383BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH ADP
1JKKA:99-2772.4A X-RAY STRUCTURE OF TERNARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE AND MG.
1JKLA:106-2911.6A X-RAY STRUCTURE OF BINARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE
1JKSA:99-2911.5A X-RAY STRUCTURE OF APO FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE
1JKTA:99-277; B:99-277TETRAGONAL CRYSTAL FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE
1JNKA:151-370THE C-JUN N-TERMINAL KINASE (JNK3S) COMPLEXED WITH MGAMP-PNP
1JQHA:1079-1279; C:1079-1279; B:1079-1279IGF-1 RECEPTOR KINASE DOMAIN
1JSTA:85-297; C:85-297PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A
1JSUA:85-297P27(KIP1)/CYCLIN A/CDK2 COMPLEX
1JSVA:85-297THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[(6-AMINO-4-PYRIMIDINYL) AMINO]BENZENESULFONAMIDE
1JVPP:87-293CRYSTAL STRUCTURE OF HUMAN CDK2 (UNPHOSPHORYLATED) IN COMPLEX WITH PKF049-365
1JWHA:7-24,A:116-333; B:7-24,B:116-333CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 HOLOENZYME
1K2PA:477-654; B:477-654CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE DOMAIN
1K3AA:1052-1253STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR KINASE
1KE5A:85-296CDK2 COMPLEXED WITH N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
1KE6A:85-296CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE
1KE7A:85-296CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE
1KE8A:85-296CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE
1KE9A:85-296CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE
1KSWA:345-519STRUCTURE OF HUMAN C-SRC TYROSINE KINASE (THR338GLY MUTANT) IN COMPLEX WITH N6-BENZYL ADP
1KV1A:111-319P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1
1KV2A:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH BIRB 796
1KWPB:141-365; A:141-365CRYSTAL STRUCTURE OF MAPKAP2
1M14A:769-982TYROSINE KINASE DOMAIN FROM EPIDERMAL GROWTH FACTOR RECEPTOR
1M17A:769-964EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE DOMAIN WITH 4-ANILINOQUINAZOLINE INHIBITOR ERLOTINIB
1M7NA:1079-1280; B:1079-1280CRYSTAL STRUCTURE OF UNACTIVATED APO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE DOMAIN
1M7QA:111-319CRYSTAL STRUCTURE OF P38 MAP KINASE IN COMPLEX WITH A DIHYDROQUINAZOLINONE INHIBITOR
1MP8A:502-684CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE (FAK)
1MQ4A:217-387CRYSTAL STRUCTURE OF AURORA-A PROTEIN KINASE
1MQBA:695-885; B:695-881CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE
1MRVA:236-429CRYSTAL STRUCTURE OF AN INACTIVE AKT2 KINASE DOMAIN
1MRYA:236-429CRYSTAL STRUCTURE OF AN INACTIVE AKT2 KINASE DOMAIN
1MUOA:217-387CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE
1NA7A:7-24,A:116-329CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2
1NVQA:98-273THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/UCN-01
1NVRA:98-273THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/STAUROSPORINE
1NVSA:98-273THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/SB218078
1NXKC:141-344; A:141-332; B:141-332; D:141-329CRYSTAL STRUCTURE OF STAUROSPORINE BOUND TO MAP KAP KINASE 2
1NY3A:141-342CRYSTAL STRUCTURE OF ADP BOUND TO MAP KAP KINASE 2
1O6KA:236-429STRUCTURE OF ACTIVATED FORM OF PKB KINASE DOMAIN S474D WITH GSK3 PEPTIDE AND AMP-PNP
1O6LA:236-429CRYSTAL STRUCTURE OF AN ACTIVATED AKT/PROTEIN KINASE B (PKB-PIF CHIMERA) TERNARY COMPLEX WITH AMP-PNP AND GSK3 PEPTIDE
1O9UA:137-383GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE
1OECA:567-762FGFR2 KINASE DOMAIN
1OGUC:85-294; A:85-295STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR
1OI9A:85-295; C:85-295STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
1OIQA:85-294IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
1OIRA:85-294IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
1OITA:85-295IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
1OIUA:85-295; C:85-294STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
1OIYA:85-295; C:85-295STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
1OKVA:85-294; C:85-296CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2
1OKWA:85-296; C:85-296CYCLIN A BINDING GROOVE INHIBITOR AC-ARG-ARG-LEU-ASN-(M-CL-PHE)-NH2
1OKYA:166-357STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
1OKZA:166-357STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH UCN-01
1OL1A:85-296; C:85-296CYCLIN A BINDING GROOVE INHIBITOR H-CIT-CIT-LEU-ILE-(P-F-PHE)-NH2
1OL2A:85-296; C:85-296CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F-PHE)-NH2
1OL5A:217-386STRUCTURE OF AURORA-A 122-403, PHOSPHORYLATED ON THR287, THR288 AND BOUND TO TPX2 1-43
1OL6A:217-383STRUCTURE OF UNPHOSPHORYLATED D274N MUTANT OF AURORA-A
1OL7A:217-387STRUCTURE OF HUMAN AURORA-A 122-403 PHOSPHORYLATED ON THR287, THR288
1OPLB:337-518; A:345-519STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
1OUKA:111-319THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A PYRIDINYLIMIDAZOLE INHIBITOR
1OUYA:111-319THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A DIHYDROPYRIDO-PYRIMIDINE INHIBITOR
1OVEA:111-319THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A DIHYDROQUINOLINONE
1OZ1A:111-319P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4-AZAINDOLE INHIBITOR
1P14A:1079-1282CRYSTAL STRUCTURE OF A CATALYTIC-LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE
1P2AA:85-295THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH A TRISUBSTITUTED NAPHTHOSTYRIL INHIBITOR
1P4FA:99-277DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH BOUND INHIBITOR FRAGMENT
1P4OA:1051-1255; B:1051-1255STRUCTURE OF APO UNACTIVATED IGF-1R KINASE DOMAIN AT 1.5A RESOLUTION.
1P5EA:85-295; C:85-295THE STRUCTURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR 4,5,6,7-TETRABROMOBENZOTRIAZOLE (TBS)
1PF8A:85-297CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH A NUCLEOSIDE INHIBITOR
1PJKA:7-24,A:116-331CRYSTAL STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT
1PKDA:85-295; C:85-295THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO-CDK2/CYCLIN A
1PKGA:673-924; B:673-925STRUCTURE OF A C-KIT KINASE PRODUCT COMPLEX
1PMEA:108-338STRUCTURE OF PENTA MUTANT HUMAN ERK2 MAP KINASE COMPLEXED WITH A SPECIFIC INHIBITOR OF HUMAN P38 MAP KINASE
1PMNA:151-370CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH AN IMIDAZOLE-PYRIMIDINE INHIBITOR
1PMQ  [entry was replaced by entry 4Z9L without any CATH domain information]
1PMUA:151-370THE CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH A PHENANTROLINE INHIBITOR
1PMVA:151-370THE STRUCTURE OF JNK3 IN COMPLEX WITH A DIHYDROANTHRAPYRAZOLE INHIBITOR
1PW2A:85-297APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2
1PXIA:85-297HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,5-DICHLORO-THIOPHEN-3-YL)-PYRIMIDIN-2-YLAMINE
1PXJA:85-297HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINE
1PXKA:85-297HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)PYRIMIDIN-2-YL]-N'-HYDROXYIMINOFORMAMIDE
1PXLA:85-297HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(4-TRIFLUOROMETHYL-PHENYL)-AMINE
1PXMA:85-297HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 3-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL
1PXNA:85-297HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-[4-(4-METHYL-2-METHYLAMINO-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL
1PXOA:85-297HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2-AMINO-4-METHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO-PHENYL)-AMINE
1PXPA:85-297HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE
1PY5A:285-500CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH INHIBITOR
1PYEA:85-294CRYSTAL STRUCTURE OF CDK2 WITH INHIBITOR
1PYXB:137-383; A:137-386GSK-3 BETA COMPLEXED WITH AMP-PNP
1Q3DA:137-355; B:137-355GSK-3 BETA COMPLEXED WITH STAUROSPORINE
1Q3WB:137-383; A:137-386GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE
1Q41A:137-386; B:137-383GSK-3 BETA COMPLEXED WITH INDIRUBIN-3'-MONOXIME
1Q4LB:137-383; A:137-386GSK-3 BETA COMPLEXED WITH INHIBITOR I-5
1Q5KB:137-384; A:137-384CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 IN COMPLEXED WITH INHIBITOR
1QCFA:345-519CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY-SELECTIVE TYROSINE KINASE INHIBITOR
1QMZA:85-295; C:85-295PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX
1QPCA:319-499STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
1QPDA:319-500STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
1QPEA:319-500STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
1QPJA:319-500CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH STAUROSPORINE.
1R0EA:137-383; B:137-383GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3-INDOLYL-4-ARYLMALEIMIDE INHIBITOR
1R0PA:1160-1357CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH THE MICROBIAL ALKALOID K-252A
1R1WA:1160-1357CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET
1R39A:111-319THE STRUCTURE OF P38ALPHA
1R3CA:111-319THE STRUCTURE OF P38ALPHA C162S MUTANT
1R78A:85-296CDK2 COMPLEX WITH A 4-ALKYNYL OXINDOLE INHIBITOR
1RJBA:696-947CRYSTAL STRUCTURE OF FLT3
1RQQA:1079-1281; B:1079-1281CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS
1RW8A:285-500CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH ATP SITE INHIBITOR
1S9IB:152-389; A:152-393X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 (MEK2)IN A COMPLEX WITH LIGAND AND MGATP
1S9JA:147-382X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
1SM2A:440-619; B:440-617CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1SNUA:440-619; B:440-617CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1SNXA:440-619; B:440-619CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1T45A:673-935STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE
1T46A:673-924STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE
1TKIA:102-338; B:102-338AUTOINHIBITED SERINE KINASE DOMAIN OF THE GIANT MUSCLE PROTEIN TITIN
1TVOA:108-336THE STRUCTURE OF ERK2 IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
1U46B:208-390; A:208-389CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED KINASE DOMAIN OF THE TYROSINE KINASE ACK1
1U4DB:208-390; A:208-389STRUCTURE OF THE ACK1 KINASE DOMAIN BOUND TO DEBROMOHYMENIALDISINE
1U54B:208-388; A:208-390CRYSTAL STRUCTURES OF THE PHOSPHORYLATED AND UNPHOSPHORYLATED KINASE DOMAINS OF THE CDC42-ASSOCIATED TYROSINE KINASE ACK1 BOUND TO AMP-PCP
1U59A:417-612CRYSTAL STRUCTURE OF THE ZAP-70 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
1UA2A:96-311; B:96-311; C:96-311; D:96-311CRYSTAL STRUCTURE OF HUMAN CDK7
1UKHA:113-332STRUCTURAL BASIS FOR THE SELECTIVE INHIBITION OF JNK1 BY THE SCAFFOLDING PROTEIN JIP1 AND SP600125
1UKIA:113-332STRUCTURAL BASIS FOR THE SELECTIVE INHIBITION OF JNK1 BY THE SCAFFOLDING PROTEIN JIP1 AND SP600125
1UNGA:85-285; B:85-288STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN.
1UNHB:85-285; A:85-288STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN.
1UNLA:85-285; B:85-285STRUCTURAL MECHANISM FOR THE INHIBITION OF CD5-P25 FROM THE ROSCOVITINE, ALOISINE AND INDIRUBIN.
1URCA:85-296; C:85-296CYCLIN A BINDING GROOVE INHIBITOR ACE-ARG-LYS-LEU-PHE-GLY
1URWA:85-295CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B]PYRIDAZINE
1UU3A:166-357STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH LY333531
1UU7A:166-357STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-2
1UU8A:166-357STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-1
1UV5A:137-382GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6-BROMOINDIRUBIN-3'-OXIME
1UVRA:166-357STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-8
1UWHA:533-722; B:533-722THE COMPLEX OF WILD TYPE B-RAF AND BAY439006
1UWJA:533-722; B:533-722THE COMPLEX OF MUTANT V599E B-RAF AND BAY439006
1V1KA:85-296CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1VJYA:285-500CRYSTAL STRUCTURE OF A NAPHTHYRIDINE INHIBITOR OF HUMAN TGF-BETA TYPE I RECEPTOR
1VR2A:919-1166HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN
1VYWA:85-297; C:85-297STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137
1VYZA:85-296STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227
1VZOA:135-345THE STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF MSK1 REVEALS A NOVEL AUTOINHIBITORY CONFORMATION FOR A DUAL KINASE PROTEIN
1W7HA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1W82A:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1W83A:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1W84A:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1W8CA:85-297CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY-8-ISOPROPYL-9H-PURIN-2-YLAMINE AND MONOMERIC CDK2
1W98A:85-295THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E
1WAKA:134-144,A:168-655X-RAY STRUCTURE OF SRPK1
1WBNA:111-319FRAGMENT BASED P38 INHIBITORS
1WBOA:111-319FRAGMENT BASED P38 INHIBITORS
1WBPA:134-144,A:168-655SRPK1 BOUND TO 9MER DOCKING MOTIF PEPTIDE
1WBSA:111-319IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WBTA:111-319IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WBVA:111-319IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WBWA:111-319IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WCCA:85-296SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY
1WFCA:111-319STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATED PROTEIN KINASE P38 (P38 MAP KINASE) THE MAMMALIAN HOMOLOGUE OF THE YEAST HOG1 PROTEIN
1WMKA:99-276; C:98-304; F:98-304; H:96-305; E:96-314; G:96-314; B:96-315; D:96-315HUMAN DEATH-ASSOCIATED KINASE DRP-1, MUTANT S308D D40
1WVWA:99-276CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1WVXA:99-276CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1WVYA:99-276CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1WZYA:108-336CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A PYRAZOLOPYRIDAZINE DERIVATIVE
1X8BA:356-360,A:380-569STRUCTURE OF HUMAN WEE1A KINASE: KINASE DOMAIN COMPLEXED WITH INHIBITOR PD0407824
1XBAA:451-636CRYSTAL STRUCTURE OF APO SYK TYROSINE KINASE DOMAIN
1XBBA:451-639CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH GLEEVEC
1XBCA:451-636CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH STAUROSPORIN
1XJDA:465-696CRYSTAL STRUCTURE OF PKC-THETA COMPLEXED WITH STAUROSPORINE AT 2A RESOLUTION
1XKKA:793-987EGFR KINASE DOMAIN COMPLEXED WITH A QUINAZOLINE INHIBITOR-GW572016
1XQZA:125-308CRYSTAL STRUCTURE OF HPIM-1 KINASE AT 2.1 A RESOLUTION
1XR1A:125-308CRYSTAL STRUCTURE OF HPIM-1 KINASE IN COMPLEX WITH AMP-PNP AT 2.1 A RESOLUTION
1XWSA:125-305CRYSTAL STRUCTURE OF THE HUMAN PIM1 KINASE DOMAIN
1Y57A:345-523STRUCTURE OF UNPHOSPHORYLATED C-SRC IN COMPLEX WITH AN INHIBITOR
1Y6AA:917-1164CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR
1Y6BA:917-1164CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR
1Y8YA:85-296CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1, 5-A]PYRIMIDINE INHIBITOR
1Y91A:85-296CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1, 5-A]PYRIMIDINE INHIBITOR
1YHSA:125-305CRYSTAL STRUCTURE OF PIM-1 BOUND TO STAUROSPORINE
1YHVA:347-541CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH TWO POINT MUTATIONS (K299R, T423E)
1YHWA:347-541CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH ONE POINT MUTATIONS (K299R)
1YI3A:125-305CRYSTAL STRUCTURE OF PIM-1 BOUND TO LY294002
1YI4A:125-305STRUCTURE OF PIM-1 BOUND TO ADENOSINE
1YI6A:343-533; B:343-533C-TERM TAIL SEGMENT OF HUMAN TYROSINE KINASE (258-533)
1YKRA:85-296CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINE INHIBITOR
1YOJA:345-535; B:346-525CRYSTAL STRUCTURE OF SRC KINASE DOMAIN
1YOLA:343-528; B:343-528CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH CGP77675
1YOMB:343-528; A:343-528CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH PURVALANOL A
1YQJA:111-319CRYSTAL STRUCTURE OF P38 ALPHA IN COMPLEX WITH A SELECTIVE PYRIDAZINE INHIBITOR
1YRPA:99-277; B:99-277CATALYTIC DOMAIN OF HUMAN ZIP KINASE PHOSPHORYLATED AT THR265
1YVJA:905-1100CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN IN COMPLEX WITH A STAUROSPORINE ANALOGUE
1YWNA:917-1164VEGFR2 IN COMPLEX WITH A NOVEL 4-AMINO-FURO[2,3-D]PYRIMIDINE
1YWVA:125-306CRYSTAL STRUCTURES OF PROTO-ONCOGENE KINASE PIM1: A TARGET OF ABERRANT SOMATIC HYPERMUTATIONS IN DIFFUSE LARGE CELL LYMPHOMA
1YXSA:125-306CRYSTAL STRUCTURE OF KINASE PIM1 WITH P123M MUTATION
1YXTA:125-306CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMPPNP
1YXUA:125-305; B:125-305; C:125-305; D:125-305CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP
1YXVA:125-306CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH 3,4-DIHYDROXY-1-METHYLQUINOLIN-2(1H)-ONE
1YXXA:125-306CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH (3E)-3-[(4-HYDROXYPHENYL)IMINO]-1H-INDOL-2(3H)-ONE
1Z57A:221-224,A:244-482CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH 10Z-HYMENIALDISINE
1Z5MA:166-357CRYSTAL STRUCTURE OF N1-[3-[[5-BROMO-2-[[3-[(1-PYRROLIDINYLCARBONYL) AMINO]PHENYL]AMINO]-4-PYRIMIDINYL]AMINO]PROPYL]-2,2-DIMETHYLPROPANEDIAMIDE COMPLEXED WITH HUMAN PDK1
1Z9XA:98-304; B:98-304; C:98-304HUMAN DRP-1 KINASE, W305S S308A D40 MUTANT, CRYSTAL FORM WITH 3 MONOMERS IN THE ASYMMETRIC UNIT
1ZLTA:98-276CRYSTAL STRUCTURE OF CHK1 COMPLEXED WITH A HYMENALDISINE ANALOG
1ZRZA:326-532CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ATYPICAL PROTEIN KINASE C-IOTA
1ZWSA:99-279; B:99-279; C:99-279; D:99-279; E:99-279; F:99-279; G:99-279; H:99-279CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
1ZYJA:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1A
1ZYSA:98-273CO-CRYSTAL STRUCTURE OF CHECKPOINT KINASE CHK1 WITH A PYRROLO-PYRIDINE INHIBITOR
1ZZ2A:111-319TWO CLASSES OF P38ALPHA MAP KINASE INHIBITORS HAVING A COMMON DIPHENYLETHER CORE BUT EXHIBITING DIVERGENT BINDING MODES
1ZZLA:111-319CRYSTAL STRUCTURE OF P38 WITH TRIAZOLOPYRIDINE
2A0CX:85-296HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II, A NOVEL 2,6,9-TRISUBSTITUTED PURINE CYCLIN-DEPENDENT KINASE INHIBITOR
2A27B:98-304; C:98-304; E:98-304; F:98-304; G:98-304; A:96-305; D:96-305; H:96-305HUMAN DRP-1 KINASE, W305S S308A D40 MUTANT, CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
2A2AA:98-304; B:98-304; C:98-304; D:98-304HIGH-RESOLUTION CRYSTALLOGRAPHIC ANALYSIS OF THE AUTOINHIBITED CONFORMATION OF A HUMAN DEATH-ASSOCIATED PROTEIN KINASE
2A4LA:85-296HUMAN CYCLIN-DEPENDENT KINASE 2 IN COMPLEX WITH ROSCOVITINE
2AC3A:162-369STRUCTURE OF HUMAN MNK2 KINASE DOMAIN
2AC5A:162-370STRUCTURE OF HUMAN MNK2 KINASE DOMAIN MUTANT D228G
2ACXB:270-468; A:270-468CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 6 BOUND TO AMPPNP
2AUHA:1079-1281CRYSTAL STRUCTURE OF THE GRB14 BPS REGION IN COMPLEX WITH THE INSULIN RECEPTOR TYROSINE KINASE
2AYPA:98-269CRYSTAL STRUCTURE OF CHK1 WITH AN INDOL INHIBITOR
2B1PA:151-370INHIBITOR COMPLEX OF JNK3
2B4SB:1079-1281; D:1079-1281CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE
2B52A:85-296HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH-042562
2B53A:85-296HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325
2B54A:85-296HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2)COMPLEXED WITH DIN-232305
2B55A:85-296HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH INDENOPYRAXOLE DIN-101312
2B7AA:932-1128; B:932-1128THE STRUCTURAL BASIS OF JANUS KINASE 2 INHIBITION BY A POTENT AND SPECIFIC PAN-JANUS KINASE INHIBITOR
2BAJA:111-319P38ALPHA BOUND TO PYRAZOLOUREA
2BAKA:111-319P38ALPHA MAP KINASE BOUND TO MPAQ
2BALA:111-319P38ALPHA MAP KINASE BOUND TO PYRAZOLOAMINE
2BAQA:111-319P38ALPHA BOUND TO RO3201195
2BDFB:343-528; A:343-528SRC KINASE IN COMPLEX WITH INHIBITOR AP23451
2BDJA:343-521SRC KINASE IN COMPLEX WITH INHIBITOR AP23464
2BHEA:85-296HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 5-BROMO-INDIRUBINE
2BHHA:85-296HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 4-HYDROXYPIPERINDINESULFONYL-INDIRUBINE
2BIKB:125-305HUMAN PIM1 PHOSPHORYLATED ON SER261
2BILB:125-306THE HUMAN PROTEIN KINASE PIM1 IN COMPLEX WITH ITS CONSENSUS PEPTIDE PIMTIDE
2BIYA:166-357STRUCTURE OF PDK1-S241A MUTANT KINASE DOMAIN
2BKZA:85-297; C:85-297STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611
2BMCA:217-387; B:217-387; C:217-387; D:217-387; E:217-387; F:217-387AURORA-2 T287D T288D COMPLEXED WITH PHA-680632
2BPMA:85-297; C:85-297STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529
2BR1A:98-276STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRBA:98-276STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRGA:98-269STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRHA:98-271STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRMA:98-274STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRNA:98-276STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BROA:98-276STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BTRA:85-296STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873
2BTSA:85-296STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032
2BUJA:102-299; B:102-297CRYSTAL STRUCTURE OF THE HUMAN SERINE-THREONINE KINASE 16 IN COMPLEX WITH STAUROSPORINE
2BVAA:398-587; B:398-587CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4
2BZHB:125-306CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1
2BZIB:125-305CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU2
2BZJA:125-305CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU3
2C0IA:319-493; B:319-493SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983
2C0OA:319-493; B:319-493SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041
2C0TA:319-493; B:319-493SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359
2C30A:484-674CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 6
2C3JA:98-270IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
2C3KA:98-270IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
2C3LA:98-273IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
2C47C:83-297; D:83-298; A:83-298; B:83-298STRUCTURE OF CASEIN KINASE 1 GAMMA 2
2C4GA:85-297; C:85-297STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514
2C5NA:85-296; C:85-297DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5OA:85-296; C:85-297DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5VA:85-296; C:85-296DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5XA:85-296; C:85-296DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5YA:85-296DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C68A:85-296CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C69A:85-296CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6DA:216-386AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH ADPNP
2C6EA:216-388; B:216-387AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH A 5-AMINOPYRIMIDINYL QUINAZOLINE INHIBITOR
2C6IA:85-296CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6KA:85-296CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6LA:85-296CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6MA:85-296CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6OA:85-296CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6TA:85-296; C:85-296CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2CCHA:85-295; C:85-295THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE
2CCIA:85-295; C:85-295CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6
2CDZA:398-590CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH CGP74514A
2CGUA:98-271IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CGVA:98-272IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CGWA:98-271IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CGXA:98-273IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CHLA:109-322STRUCTURE OF CASEIN KINASE 1 GAMMA 3
2CJMA:85-292; C:85-297MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE
2CKEA:98-301; B:98-301; C:98-301; D:98-301HUMAN DEATH-ASSOCIATED DRP-1 KINASE IN COMPLEX WITH INHIBITOR
2CLXA:85-2964-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY, CRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR EFFECTS
2CMWA:122-339STRUCTURE OF HUMAN CASEIN KINASE 1 GAMMA-1 IN COMPLEX WITH 2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE (CASP TARGET)
2CN5A:304-504CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH ADP
2CN8A:304-503CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH DEBROMOHYMENIALDISINE
2DQ7X:87-263CRYSTAL STRUCTURE OF FYN KINASE DOMAIN COMPLEXED WITH STAUROSPORINE
2DS1A:85-296HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
2DUVA:85-296STRUCTURE OF CDK2 WITH A 3-HYDROXYCHROMONES
2DWBA:217-383AURORA-A KINASE COMPLEXED WITH AMPPNP
2DYLA:216-418CRYSTAL STRUCTURE OF HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 ACTIVATED MUTANT (S287D, T291D)
2E14  [entry was replaced by entry 3W55 without any CATH domain information]
2E2BA:318-497; B:318-497CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH INNO-406
2E9NA:98-270STRUCTURE OF H-CHK1 COMPLEXED WITH A767085
2E9OA:98-270STRUCTURE OF H-CHK1 COMPLEXED WITH AA582939
2E9PA:98-270STRUCTURE OF H-CHK1 COMPLEXED WITH A771129
2E9UA:98-270STRUCTURE OF H-CHK1 COMPLEXED WITH A780125
2E9VA:98-269; B:98-269STRUCTURE OF H-CHK1 COMPLEXED WITH A859017
2EB2A:793-990CRYSTAL STRUCTURE OF MUTATED EGFR KINASE DOMAIN (G719S)
2EB3A:793-990CRYSTAL STRUCTURE OF MUTATED EGFR KINASE DOMAIN (L858R) IN COMPLEX WITH AMPPNP
2ESMA:160-358; B:160-358CRYSTAL STRUCTURE OF ROCK 1 BOUND TO FASUDIL
2ETKA:160-358; B:160-358CRYSTAL STRUCTURE OF ROCK 1 BOUND TO HYDROXYFASUDIL
2ETMA:502-684; B:502-684CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN COMPLEXED WITH 7H-PYRROLO [2,3-D] PYRIMIDINE DERIVATIVE
2ETRA:160-358; B:160-358CRYSTAL STRUCTURE OF ROCK I BOUND TO Y-27632
2EU9A:216-219,A:239-481CRYSTAL STRUCTURE OF CLK3
2EVAA:109-497STRUCTURAL BASIS FOR THE INTERACTION OF TAK1 KINASE WITH ITS ACTIVATING PROTEIN TAB1
2EXCX:151-370INHIBITOR COMPLEX OF JNK3
2EXEA:198-479CRYSTAL STRUCTURE OF THE PHOSPHORYLATED CLK3
2EXMA:85-296HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE
2F4JA:318-499STRUCTURE OF THE KINASE DOMAIN OF AN IMATINIB-RESISTANT ABL MUTANT IN COMPLEX WITH THE AURORA KINASE INHIBITOR VX-680
2F57B:526-718; A:526-715CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 5
2FB8A:534-720; B:534-720STRUCTURE OF THE B-RAF KINASE DOMAIN BOUND TO SB-590885
2FGIA:564-757; B:564-757CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074
2FO0A:337-530ORGANIZATION OF THE SH3-SH2 UNIT IN ACTIVE AND INACTIVE FORMS OF THE C-ABL TYROSINE KINASE
2FSLX:111-319MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327S) ACTIVATING MUTANT FORM-A
2FSMX:111-319MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327S) ACTIVATING MUTANT FORM-B
2FSOX:111-319MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A) ACTIVATING MUTANT
2FSTX:111-319MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327L) ACTIVATING MUTANT
2FVDA:85-296CYCLIN DEPENDENT KINASE 2 (CDK2) WITH DIAMINOPYRIMIDINE INHIBITOR
2G01A:113-332; B:113-332PYRAZOLOQUINOLONES AS NOVEL, SELECTIVE JNK1 INHIBITORS
2G15A:1160-1346STRUCTURAL CHARACTERIZATION OF AUTOINHIBITED C-MET KINASE
2G1TA:318-499; B:318-499; C:318-499; D:318-499A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
2G2FA:318-499; B:318-499A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
2G2HA:337-518; B:337-518A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
2G2IA:318-499; B:318-499A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
2G9XC:85-294; A:85-295STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR NU6271
2GDOA:98-2734-(AMINOALKYLAMINO)-3-BENZIMIDAZOLE-QUINOLINONES AS POTENT CHK1 INHIBITORS
2GFSA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO3201195
2GHGA:98-270H-CHK1 COMPLEXED WITH A431994
2GMXA:113-332; B:113-332SELECTIVE AMINOPYRIDINE-BASED C-JUN N-TERMINAL KINASE INHIBITORS WITH CELLULAR ACTIVITY
2GQGA:318-500; B:318-499X-RAY CRYSTAL STRUCTURE OF DASATINIB (BMS-354825) BOUND TO ACTIVATED ABL KINASE DOMAIN
2GS2A:769-966CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN
2GS6A:769-967CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AN ATP ANALOG-PEPTIDE CONJUGATE
2GS7B:769-959; A:769-959CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
2GSFA:702-904THE HUMAN EPHA3 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION
2GU8A:14-32,A:127-317DISCOVERY OF 2-PYRIMIDYL-5-AMIDOTHIOPHENES AS NOVEL AND POTENT INHIBITORS FOR AKT: SYNTHESIS AND SAR STUDIES
2H6DA:96-278PROTEIN KINASE DOMAIN OF THE HUMAN 5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (AMPK ALPHA-2 CHAIN)
2H8HA:345-519SRC KINASE IN COMPLEX WITH A QUINAZOLINE INHIBITOR
2H96A:113-332; B:113-332DISCOVERY OF POTENT, HIGHLY SELECTIVE, AND ORALLY BIOAVAILABLE PYRIDINE CARBOXAMIDE C-JUN NH2-TERMINAL KINASE INHIBITORS
2HAKE:132-321; F:132-321; A:132-321; C:132-321; D:132-321; G:132-321; B:132-321; H:136-316CATALYTIC AND UBIQUTIN-ASSOCIATED DOMAINS OF MARK1/PAR-1
2HCKA:345-519; B:345-519SRC FAMILY KINASE HCK-QUERCETIN COMPLEX
2HIWA:336-517; B:336-517CRYSTAL STRUCTURE OF INACTIVE CONFORMATION ABL KINASE CATALYTIC DOMAIN COMPLEXED WITH TYPE II INHIBITOR
2HK5A:319-497HCK KINASE IN COMPLEX WITH LCK TARGETTED INHIBITOR PG-1009247
2HOGA:98-280CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 20
2HW6A:127-335; B:127-334CRYSTAL STRUCTURE OF MNK1 CATALYTIC DOMAIN
2HW7A:162-371CRYSTAL STRUCTURE OF MNK2-D228G IN COMPLEX WITH STAUROSPORINE
2HXLA:98-276CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 1
2HXQA:98-276CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 2
2HY0A:98-280CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 22
2HY81:347-541PAK1 COMPLEX WITH ST2001
2HYYA:318-498; B:318-498; D:318-498; C:318-498HUMAN ABL KINASE DOMAIN IN COMPLEX WITH IMATINIB (STI571, GLIVEC)
2HZ0A:318-497; B:318-497ABL KINASE DOMAIN IN COMPLEX WITH NVP-AEG082
2HZ4A:318-500; C:318-500; B:318-498ABL KINASE DOMAIN UNLIGATED AND IN COMPLEX WITH TETRAHYDROSTAUROSPORINE
2HZIA:318-500; B:318-500ABL KINASE DOMAIN IN COMPLEX WITH PD180970
2I0EB:423-619; A:427-620STRUCTURE OF CATALYTIC DOMAIN OF HUMAN PROTEIN KINASE C BETA II COMPLEXED WITH A BISINDOLYLMALEIMIDE INHIBITOR
2I0HA:111-319THE STRUCTURE OF P38ALPHA IN COMPLEX WITH AN ARYLPYRIDAZINONE
2I0VA:666-910C-FMS TYROSINE KINASE IN COMPLEX WITH A QUINOLONE INHIBITOR
2I0YA:666-910CFMS TYROSINE KINASE (FGF KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR
2I1MA:666-910CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR
2I40A:85-296; C:85-296CDK2/CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE INHIBITOR
2I6LB:113-320; A:113-321CRYSTAL STRUCTURE OF HUMAN MITOGEN ACTIVATED PROTEIN KINASE 6 (MAPK6)
2IJMA:502-684; B:502-684CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN WITH 2 MOLECULES IN THE ASYMMETRIC UNIT COMPLEXED WITH ADP AND ATP
2IN6A:356-360,A:380-569WEE1 KINASE COMPLEX WITH INHIBITOR PD311839
2IO6A:356-360,A:380-569WEE1 KINASE COMPLEXED WITH INHIBITOR PD330961
2ITPA:793-1004CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AEE788
2ITTA:793-987CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AEE788
2ITVA:793-987CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AMP-PNP
2ITWA:793-984CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AFN941
2ITXA:793-989CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
2ITZA:793-987CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH IRESSA
2IVSA:807-1010; B:807-1010CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED RET TYROSINE KINASE DOMAIN
2IVTA:807-1010CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN
2IVUA:807-1010CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR ZD6474
2IVVA:807-1010CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR PP1
2IW6A:85-295; C:85-295STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
2IW8A:85-295; C:85-294STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR
2IW9C:85-294; A:85-297STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
2IWIA:121-288; B:121-287CRYSTAL STRUCTURE OF THE HUMAN PIM2 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1
2IZRA:120-334STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2IZSA:120-333STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2IZTA:120-334STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2IZUA:120-334STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2J0IA:398-589CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4
2J2IB:125-305CRYSTAL STRUCTURE OF THE HUMAB PIM1 IN COMPLEX WITH LY333531
2J4ZA:217-387; B:217-387STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-680626
2J50A:217-387; B:217-387STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-739358
2J51A:111-308CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE BOUND TO 5-AMINO-3-((4-(AMINOSULFONYL)PHENYL)AMINO)-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE
2J5EA:793-989CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 13-JAB
2J5FA:793-991CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 34-JAB
2J6MA:793-1004CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AEE788
2J7TA:113-317CRYSTAL STRUCTURE OF HUMAN SERINE THREONINE KINASE-10 BOUND TO SU11274
2J90B:99-280; A:99-278CRYSTAL STRUCTURE OF HUMAN ZIP KINASE IN COMPLEX WITH A TETRACYCLIC PYRIDONE INHIBITOR (PYRIDONE 6)
2J9MA:85-296CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH MACROCYCLIC AMINOPYRIMIDINE
2JAMB:101-302; A:101-303CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE I G
2JAVA:46-68,A:90-279HUMAN KINASE WITH PYRROLE-INDOLINONE LIGAND
2JBOA:141-342PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-1, SOAKING)
2JBPB:141-342; I:141-342; D:141-342; F:141-342; G:141-342; E:141-342; H:141-342; C:141-342; A:141-342; K:141-342; L:141-342; J:141-325PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-2, CO-CRYSTALLIZATION)
2JC6A:101-279; C:101-279CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE 1D
2JDOA:236-429STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE
2JDRA:236-429STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A-443654
2JEDB:464-658; A:465-654THE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF THE PROTEIN KINASE C THETA IN COMPLEX WITH NVP-XAA228 AT 2.32A RESOLUTION.
2JFLA:111-308CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE ( DIPHOSPHORYLATED FORM) BOUND TO 5- AMINO-3-((4-( AMINOSULFONYL)PHENYL)AMINO)-N-(2,6- DIFLUOROPHENYL)-1H-1,2, 4-TRIAZOLE-1-CARBOTHIOAMIDE
2JFMA:111-308CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE (UNLIGANDED FORM)
2JGZA:85-288CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B
2JIIA:262-461; B:262-461STRUCTURE OF VACCINIA RELATED KINASE 3
2JITA:793-1010; B:793-1010CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION
2JIUB:793-992; A:793-1010CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPLEX WITH AEE788
2JIVB:793-982; A:793-984CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPEX WITH HKI-272
2JLDA:137-355; B:137-384EXTREMELY TIGHT BINDING OF RUTHENIUM COMPLEX TO GLYCOGEN SYNTHASE KINASE 3
2NO3A:113-332; B:113-332NOVEL 4-ANILINOPYRIMIDINES AS POTENT JNK1 INHIBITORS
2NPQA:111-319A NOVEL LIPID BINDING SITE IN THE P38 ALPHA MAP KINASE
2NRUA:265-458; B:265-458; C:265-458; D:265-458CRYSTAL STRUCTURE OF IRAK-4
2NRYD:265-460; C:265-458; A:265-458; B:265-458CRYSTAL STRUCTURE OF IRAK-4
2O0UA:151-363CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH N-{3-CYANO-6-[3-(1-PIPERIDINYL)PROPANOYL]-4,5,6,7-TETRAHYDROTHIENO[2,3-C]PYRIDIN-2-YL}-1-NAPHTHALENECARBOXAMIDE
2O2UA:151-363CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH N-(3-CYANO-4,5,6,7-TETRAHYDRO-1-BENZOTHIEN-2-YL)-2-FLUOROBENZAMIDE
2O3PA:125-306CRYSTAL STRUCTURE OF PIM1 WITH QUERCETIN
2O5KA:137-384CRYSTAL STRUCTURE OF GSK3BETA IN COMPLEX WITH A BENZOIMIDAZOL INHIBITOR
2O63A:125-306CRYSTAL STRUCTURE OF PIM1 WITH MYRICETIN
2O64A:125-306CRYSTAL STRUCTURE OF PIM1 WITH QUERCETAGETIN
2O65A:125-306CRYSTAL STRUCTURE OF PIM1 WITH PENTAHYDROXYFLAVONE
2O8YB:266-459; A:266-459APO IRAK4 KINASE DOMAIN
2OBJA:125-305CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH INHIBITOR
2OF2A:319-500CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 8 BOUND TO LCK
2OF4A:319-500CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 1 BOUND TO LCK
2OFUA:319-500X-RAY CRYSTAL STRUCTURE OF 2-AMINOPYRIMIDINE CARBAMATE 43 BOUND TO LCK
2OFVA:321-498; B:321-499CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 1 BOUND TO LCK
2OG8B:321-500; A:321-499CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 36 BOUND TO LCK
2OGVA:666-910CRYSTAL STRUCTURE OF THE AUTOINHIBITED HUMAN C-FMS KINASE DOMAIN
2OH4A:917-1164CRYSTAL STRUCTURE OF VEGFR2 WITH A BENZIMIDAZOLE-UREA INHIBITOR
2OI4X:125-306CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH FLUORINATED RUTHENIUM PYRIDOCARBAZOLE
2OIBD:265-459; B:265-459; A:265-458; C:265-458CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN APO FORM
2OICD:265-459; B:265-459; A:265-458; C:265-458CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN COMPLEXED WITH STAUROSPORINE
2OIDD:265-459; A:265-458; B:265-459; C:265-458CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN COMPLEXED WITH AMPPNP
2OJ9A:1049-1249STRUCTURE OF IGF-1R KINASE DOMAIN COMPLEXED WITH A BENZIMIDAZOLE INHIBITOR
2OJGA:106-336CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2OJIA:106-336CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-BENZYL-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2OJJA:106-336CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2OK1A:151-370CRYSTAL STRUCTURE OF JNK3 BOUND TO N-BENZYL-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2OKRD:111-319; A:111-319CRYSTAL STRUCTURE OF THE P38A-MAPKAP KINASE 2 HETERODIMER
2ONLA:111-319; C:143-332; D:143-332; B:111-319CRYSTAL STRUCTURE OF THE P38A-MAPKAP KINASE 2 HETERODIMER
2OO8X:908-1117SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS
2OSCA:908-1116SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS
2OU7A:137-309STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1
2OW3A:137-385; B:137-386GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH BIS-(INDOLE)MALEIMIDE PYRIDINOPHANE INHIBITOR
2OWBA:137-309STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1
2OZAB:111-319; A:143-332STRUCTURE OF P38ALPHA COMPLEX
2OZOA:419-602AUTOINHIBITED INTACT HUMAN ZAP-70
2P0CA:674-859; B:674-859CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER
2P2HA:919-1166CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDINYL-TRIAZINE INHIBITOR
2P2IA:919-1166; B:919-1166CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NICOTINAMIDE INHIBITOR
2P33A:151-363SYNTHESIS AND SAR OF AMINOPYRIMIDINES AS NOVEL C-JUN N-TERMINAL KINASE (JNK) INHIBITORS
2P3GX:141-364CRYSTAL STRUCTURE OF A PYRROLOPYRIDINE INHIBITOR BOUND TO MAPKAP KINASE-2
2P4IB:908-1117; A:908-1117EVOLUTION OF A HIGHLY SELECTIVE AND POTENT 2-(PYRIDIN-2-YL)-1,3,5-TRIAZINE TIE-2 KINASE INHIBITOR
2P55A:147-382X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
2PE0A:166-357CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-HYDROXY-3-[1-(1H-PYRROL-2-YL)-ETH-(Z)-YLIDENE]-1,3-DIHYDRO-INDOL-2-ONE COMPLEX
2PE1A:166-357CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) {2-OXO-3-[1-(1H-PYRROL-2-YL)-ETH-(Z)-YLIDENE]-2,3-DIHYDRO-1H-INDOL-5-YL}-UREA {BX-517} COMPLEX
2PE2A:166-357CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 3-{5-[2-OXO-5-UREIDO-1,2-DIHYDRO-INDOL-(3Z)-YLIDENEMETHYL]-1H-PYRROL-3-YL}-N-(2-PIPERIDIN-1-YL-ETHYL)-BENZAMIDE COMPLEX
2PKJ  [entry was replaced by entry 3MH0 without any CATH domain information]
2PL0A:319-498LCK BOUND TO IMATINIB
2PSQA:567-762; B:567-762CRYSTAL STRUCTURE OF UNPHOSPHORYLATED UNACTIVATED WILD TYPE FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN
2PTJ  [entry was replaced by entry 3MH3 without any CATH domain information]
2PTO  [entry was replaced by entry 3MH2 without any CATH domain information]
2PV5  [entry was replaced by entry 3MGY without any CATH domain information]
2PV8  [entry was replaced by entry 3MH1 without any CATH domain information]
2PVFA:567-762CRYSTAL STRUCTURE OF TYROSINE PHOSPHORYLATED ACTIVATED FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH ATP ANALOG AND SUBSTRATE PEPTIDE
2PVRA:7-24,A:116-329CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 (C-TERMINAL DELETION MUTANT 1-335) IN COMPLEX WITH TWO SULFATE IONS
2PVYA:567-762; D:567-762; B:567-762; C:567-762CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME.
2PWLB:567-762; A:567-762CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549H MUTATION RESPONSIBLE FOR CROUZON SYNDROME.
2PY3B:567-762; A:567-762CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565G MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
2PZ5A:567-762; B:567-762CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549T MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
2PZPB:567-762; A:567-762CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K526E MUTATION RESPONSIBLE FOR CROUZON SYNDROME
2PZRA:567-762; B:567-762CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K641R MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
2PZYC:141-342; D:141-342; A:141-342; B:141-342STRUCTURE OF MK2 COMPLEXED WITH COMPOUND 76
2Q0BB:567-762; A:567-762CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565A MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
2Q0NA:398-591STRUCTURE OF HUMAN P21 ACTIVATING KINASE 4 (PAK4) IN COMPLEX WITH A CONSENSUS PEPTIDE
2QD9A:111-319P38 ALPHA MAP KINASE INHIBITOR BASED ON HETEROBICYCLIC SCAFFOLDS
2QHMA:98-280CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 2A
2QHNA:98-280CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 1A
2QLUA:270-484CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE II KINASE DOMAIN FROM HUMAN
2QNJB:135-324; A:135-324KINASE AND UBIQUITIN-ASSOCIATED DOMAINS OF MARK3/PAR-1
2QO2A:702-904HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, APO STRUCTURE
2QO7A:702-904HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, AMP-PNP BOUND
2QO9A:703-904HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, PHOSPHORYLATED, AMP-PNP BOUND
2QOBA:703-906HUMAN EPHA3 KINASE DOMAIN, BASE STRUCTURE
2QOCA:703-906HUMAN EPHA3 KINASE DOMAIN, PHOSPHORYLATED, AMP-PNP BOUND STRUCTURE
2QODA:702-904HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y602F MUTANT
2QOFA:702-906HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F MUTANT
2QOIA:702-904HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F DOUBLE MUTANT
2QOKA:702-904HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:S768A TRIPLE MUTANT
2QOLA:702-904HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596:Y602:S768G TRIPLE MUTANT
2QONA:702-905HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742A TRIPLE MUTANT
2QOOA:702-904HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742F TRIPLE MUTANT
2QOQA:702-906HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, BASE, AMP-PNP BOUND STRUCTURE
2QU5A:919-1166CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZIMIDAZOLE INHIBITOR
2QU6A:919-1166; B:919-1165CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR
2R0UA:98-280CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 54
2R2PA:756-946KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 5 (EPHA5)
2R3FA:85-296CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3GA:85-296CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3HA:85-296CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3IA:85-296CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3JA:85-296CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3KA:85-296CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3LA:85-296CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3MA:85-296CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3NA:85-296CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3OA:85-296CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3PA:85-296CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3QA:85-296CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3RA:85-296CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R4BA:799-978; B:799-978ERBB4 KINASE DOMAIN COMPLEXED WITH A THIENOPYRIMIDINE INHIBITOR
2R5TA:183-372CRYSTAL STRUCTURE OF INACTIVE SERUM AND GLUCOCORTICOID-REGULATED KINASE 1 IN COMPLEX WITH AMP-PNP
2R7BA:166-357CRYSTAL STRUCTURE OF THE PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK-1)CATALYTIC DOMAIN BOUND TO A DIBENZONAPHTHYRIDINE INHIBITOR
2R9SA:151-380; B:151-380C-JUN N-TERMINAL KINASE 3 WITH 3,5-DISUBSTITUTED QUINOLINE INHIBITOR
2REIA:714-902KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7)
2RF9A:769-959; B:769-961CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
2RFDB:769-965; A:769-965CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
2RFEA:769-968; D:769-985; B:769-959; C:769-959CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
2RFNA:1160-1351; B:1160-1351X-RAY STRUCTURE OF C-MET WITH INHIBITOR.
2RFSA:1160-1346X-RAY STRUCTURE OF SU11274 BOUND TO C-MET
2RG5A:111-319PHENYLALANINE PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 11B
2RG6A:111-319PHENYLALANINE PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 11J
2RGPA:793-987STRUCTURE OF EGFR IN COMPLEX WITH HYDRAZONE, A POTENT DUAL INHIBITOR
2RKUA:137-309STRUCTURE OF PLK1 IN COMPLEX WITH BI2536
2RL5A:919-1166CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A 2,3-DIHYDRO-1,4-BENZOXAZINE INHIBITOR
2SRCA:345-519CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP
2UUEA:85-296; C:85-297REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
2UV2A:111-308CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE BOUND TO 4-(4-( 5-CYCLOPROPYL-1H-PYRAZOL-3-YLAMINO)-QUINAZOLIN-2-YLAMINO)-PHENYL)-ACETONITRILE
2UW9A:236-429STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4-CHLORO-PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE
2UZBA:85-296; C:85-296CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZDA:85-296; C:85-296CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZEA:85-296; C:85-297CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZLA:85-297; C:85-297CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZNA:85-296CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZOA:85-296CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2V0DA:85-296CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2V22A:85-296; C:85-297REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
2V55A:160-358; C:160-358MECHANISM OF MULTI-SITE PHOSPHORYLATION FROM A ROCK-I:RHOE COMPLEX STRUCTURE
2V5QA:137-309; B:137-309CRYSTAL STRUCTURE OF WILD-TYPE PLK-1 KINASE DOMAIN IN COMPLEX WITH A SELECTIVE DARPIN
2V7AA:318-499; B:318-499CRYSTAL STRUCTURE OF THE T315I ABL MUTANT IN COMPLEX WITH THE INHIBITOR PHA-739358
2V7OA:95-302CRYSTAL STRUCTURE OF HUMAN CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE II GAMMA
2VAGA:221-224,A:244-481CRYSTAL STRUCTURE OF DI-PHOSPHORYLATED HUMAN CLK1 IN COMPLEX WITH A NOVEL SUBSTITUTED INDOLE INHIBITOR
2VD5B:155-362; A:155-357STRUCTURE OF HUMAN MYOTONIC DYSTROPHY PROTEIN KINASE IN COMPLEX WITH THE BISINDOYLMALEIDE INHIBITOR BIM VIII
2VN9A:93-309; B:93-309CRYSTAL STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA ISOFORM 1, CAMKD
2VTAA:85-296IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTHA:85-296IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN
2VTIA:85-296IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTJA:85-296IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTLA:85-296IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTMA:85-296IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTNA:85-296IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTOA:85-296IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTPA:85-296IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTQA:85-296IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTRA:85-296IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTSA:85-296IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTTA:85-296IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VU3A:85-296IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VV9A:85-296CDK2 IN COMPLEX WITH AN IMIDAZOLE PIPERAZINE
2VWUA:696-884EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWVA:696-884EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWWA:696-884EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWXA:696-884EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWYA:696-884EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWZA:696-884EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VX0A:696-884EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VX1A:696-884EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VZ6A:92-299; B:92-300STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE TYPE II ALPHA (CAMK2A) IN COMPLEX WITH INDIRUBIN E804
2W05A:85-296STRUCTURE OF CDK2 IN COMPLEX WITH AN IMIDAZOLYL PYRIMIDINE, COMPOUND 5B
2W06A:85-296STRUCTURE OF CDK2 IN COMPLEX WITH AN IMIDAZOLYL PYRIMIDINE, COMPOUND 5C
2W0JA:304-510CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH NSC 109555, A SPECIFIC INHIBITOR
2W17A:85-296CDK2 IN COMPLEX WITH THE IMIDAZOLE PYRIMIDINE AMIDE, COMPOUND (S)-8B
2W1CA:217-387STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1DA:217-387STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1EA:217-387STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1FA:217-387STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1GA:217-387STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1HA:85-296FRAGMENT-BASED DISCOVERY OF THE PYRAZOL-4-YL UREA (AT9283), A MULTI-TARGETED KINASE INHIBITOR WITH POTENT AURORA KINASE ACTIVITY
2W4JA:99-277X-RAY STRUCTURE OF A DAP-KINASE 2-277
2W4KA:98-302X-RAY STRUCTURE OF A DAP-KINASE 2-302
2W4OA:121-300CRYSTAL STRUCTURE OF HUMAN CAMK4 IN COMPLEX WITH 4-AMINO( SULFAMOYL-PHENYLAMINO)-TRIAZOLE-CARBOTHIOIC ACID (2,6-DIFLUORO-PHENYL)-AMIDE)
2W5AA:46-68,A:90-279HUMAN NEK2 KINASE ADP-BOUND
2W5BA:46-68,A:90-279HUMAN NEK2 KINASE ATPGAMMAS-BOUND
2W5HA:48-68,A:90-279HUMAN NEK2 KINASE APO
2W7XA:304-510CELLULAR INHIBITION OF CHECKPOINT KINASE 2 AND POTENTIATION OF CYTOTOXIC DRUGS BY NOVEL CHK2 INHIBITOR PV1019
2W96B:98-294CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2W99B:98-294CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2W9FB:98-294CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2W9ZB:98-294CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2WAJA:151-368CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH A 1-ARYL-3,4-DIHYDROISOQUINOLINE INHIBITOR
2WD1A:1160-1346HUMAN C-MET KINASE IN COMPLEX WITH AZAINDOLE INHIBITOR
2WELA:94-276CRYSTAL STRUCTURE OF SU6656-BOUND CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II DELTA IN COMPLEX WITH CALMODULIN
2WEVA:85-296; C:85-297TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2WFYA:85-296; C:85-297TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2WGJA:1160-1345X-RAY STRUCTURE OF PF-02341066 BOUND TO THE KINASE DOMAIN OF C-MET
2WHBA:85-296; C:85-297TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2WIHA:85-297; C:85-297STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125
2WIPC:85-296; A:85-297STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1-METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H] QUINAZOLINE-3-CARBOXYLIC ACID
2WKMA:1160-1345X-RAY STRUCTURE OF PHA-00665752 BOUND TO THE KINASE DOMAIN OF C-MET
2WMQA:98-269CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMRA:98-270CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMSA:98-270CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMTA:98-270CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMUA:98-270CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMVA:98-270CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMWA:98-269CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMXA:98-269CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WOTA:285-500ALK5 IN COMPLEX WITH 4-((5,6-DIMETHYL-2-(2-PYRIDYL)-3-PYRIDYL)OXY)-N-(3,4,5-TRIMETHOXYPHENYL)PYRIDIN-2-AMINE
2WOUA:285-496ALK5 IN COMPLEX WITH 4-((4-((2,6-DIMETHYL-3-PYRIDYL)OXY)-2-PYRIDYL)AMINO)BENZENESULFONAMIDE
2WPAA:85-297; C:85-297OPTIMISATION OF 6,6-DIMETHYL PYRROLO 3,4-C PYRAZOLES: IDENTIFICATION OF PHA-793887, A POTENT CDK INHIBITOR SUITABLE FOR INTRAVENOUS DOSING
2WQBA:905-1112STRUCTURE OF THE TIE2 KINASE DOMAIN IN COMPLEX WITH A THIAZOLOPYRIMIDINE INHIBITOR
2WQMA:73-95,A:115-300STRUCTURE OF APO HUMAN NEK7
2WQNA:73-95,A:115-300STRUCTURE OF ADP-BOUND HUMAN NEK7
2WQOA:46-68,A:90-279STRUCTURE OF NEK2 BOUND TO THE AMINOPYRIDINE CCT241950
2WTCA:304-512CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR
2WTDA:304-512CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR
2WTIA:304-512CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR
2WTJA:304-512CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR
2WTVA:217-386; B:217-386; C:217-386; D:217-386AURORA-A INHIBITOR STRUCTURE
2WTWA:217-386AURORA-A INHIBITOR STRUCTURE (2ND CRYSTAL FORM)
2WU6A:216-219,A:239-483CRYSTAL STRUCTURE OF THE HUMAN CLK3 IN COMPLEX WITH DKI
2WU7A:216-219,A:239-482CRYSTAL STRUCTURE OF THE HUMAN CLK3 IN COMPLEX WITH V25
2WXVA:85-297; C:85-297STRUCTURE OF CDK2-CYCLIN A WITH A PYRAZOLO(4,3-H) QUINAZOLINE-3-CARBOXAMIDE INHIBITOR
2X0GA:96-320X-RAY STRUCTURE OF A DAP-KINASE CALMODULIN COMPLEX
2X1NA:85-296; C:85-297TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2X2KA:807-1010CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
2X2LA:807-1010CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
2X2MA:807-1010; B:807-1010CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
2X39A:236-429STRUCTURE OF 4-AMINO-N-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D) PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE BOUND TO PKB
2X6DA:217-386AURORA-A BOUND TO AN INHIBITOR
2X6EA:217-386AURORA-A BOUND TO AN INHIBITOR
2X7GA:146-156,A:180-699STRUCTURE OF HUMAN SERINE-ARGININE-RICH PROTEIN-SPECIFIC KINASE 2 (SRPK2) BOUND TO PURVALANOL B
2X81A:217-387STRUCTURE OF AURORA A IN COMPLEX WITH MLN8054
2X8DA:98-281DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
2X8EA:98-270DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
2X8IA:98-269DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
2XB7A:1199-1389STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH NVP-TAE684
2XBAA:1199-1389STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PHA-E429
2XCHA:166-357CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
2XCKA:166-357CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
2XEYA:98-269CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2XEZA:98-270CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2XF0A:98-270CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2XH5A:236-429STRUCTURE OF 4-(4-TERT-BUTYLBENZYL)-1-(7H-PYRROLO(2,3-D) PYRIMIDIN-4-YL)PIPERIDIN-4-AMINE BOUND TO PKB
2XNEA:217-387STRUCTURE OF AURORA-A BOUND TO AN IMIDAZOPYRAZINE INHIBITOR
2XNGA:217-386STRUCTURE OF AURORA-A BOUND TO A SELECTIVE IMIDAZOPYRAZINE INHIBITOR
2XP2A:1199-1389STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB (PF-02341066)
2YWPA:98-270CRYSTAL STRUCTURE OF CHK1 WITH A UREA INHIBITOR
2YZAA:96-278CRYSTAL STRUCTURE OF KINASE DOMAIN OF HUMAN 5'-AMP-ACTIVATED PROTEIN KINASE ALPHA-2 SUBUNIT MUTANT (T172D)
2Z2WA:356-360,A:380-571HUMAN WEE1 KINASE COMPLEXED WITH INHIBITOR PF0335770
2Z7QA:148-340CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK-1 BOUND TO AMP-PCP
2Z7RA:148-340CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK1 BOUND TO STAUROSPORINE
2Z7SA:148-340CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK1 BOUND TO PURVALNOL A
2Z8CA:1079-1281PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH (4-{[5-CARBAMOYL-4-(3-METHYLANILINO)PYRIMIDIN-2-YL]AMINO}PHENYL)ACETIC ACID
2ZAZA:111-319CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH 4-ANILINO QUINOLINE INHIBITOR
2ZB0A:111-319CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH BIPHENYL AMIDE INHIBITOR
2ZB1A:111-319CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH BIPHENYL AMIDE INHIBITOR
2ZDTA:151-368CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH AN ISOQUINOLONE INHIBITOR
2ZDUA:151-368CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH AN ISOQUINOLONE INHIBITOR
2ZJWA:7-24,A:116-331CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH ELLAGIC ACID
2ZM1A:319-501CRYSTAL STRUCTURE OF IMIDAZO PYRAZIN 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
2ZM3A:1079-1279; B:1079-1279; C:1079-1279; D:1079-1279COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR
2ZM4A:319-501CRYSTAL STRUCTURE OF IMIDAZO QUINOXALINE 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394)
2ZOQA:125-355; B:125-355STRUCTURAL DISSECTION OF HUMAN MITOGEN-ACTIVATED KINASE ERK1
2ZV2A:271-449CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2, BETA, CAMKK2 KINASE DOMAIN IN COMPLEX WITH STO-609
2ZYBA:319-501CRYSTAL STRUCTURE OF PHENYLIMIDAZO PYRAZIN 2 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3A2CF:141-342; D:141-342; C:141-342; E:141-342; H:141-342; I:141-342; J:141-342; L:141-342; B:141-342; G:141-342; A:141-342; K:141-342CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR COMPLEX BOUND TO MAPKAP KINASE-2 (MK2)
3A4OX:91-274LYN KINASE DOMAIN
3A4PA:1160-1357HUMAN C-MET KINASE DOMAIN COMPLEXED WITH 6-BENZYLOXYQUINOLINE INHIBITOR
3A60B:179-372; A:179-371CRYSTAL STRUCTURE OF UNPHOSPHORYLATED P70S6K1 (FORM I)
3A61A:179-371CRYSTAL STRUCTURE OF UNPHOSPHORYLATED P70S6K1 (FORM II)
3A62A:179-372CRYSTAL STRUCTURE OF PHOSPHORYLATED P70S6K1
3A8WA:330-533; B:330-533CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN
3A8XB:330-533; A:330-533CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN
3AC1A:319-502CRYSTAL STRUCTURE OF PYRAZIN DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC2A:319-502CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC3A:319-502CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC4A:319-502CRYSTAL STRUCTURE OF TRIAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC5A:319-502CRYSTAL STRUCTURE OF TRIAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC8A:319-501CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3ACJA:319-502CRYSTAL STRUCTURE OF IMIDAZO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3ACKA:319-502CRYSTAL STRUCTURE OF PYRROLO PYRAZINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3B2TA:567-759; B:567-759STRUCTURE OF PHOSPHOTRANSFERASE
3B2WA:321-500CRYSTAL STRUCTURE OF PYRIMIDINE AMIDE 11 BOUND TO LCK
3B8QA:919-1166; B:919-1166CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR
3B8RA:919-1166; B:919-1166CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR
3BBTB:774-973; D:774-963CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN COMPLEX WITH LAPATINIB
3BBWB:774-973; A:774-966CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN ITS INACTIVE CONFORMATION
3BCEB:774-968; A:774-966; C:774-965CRYSTAL STRUCTURE OF THE ERBB4 KINASE
3BE2A:919-1166CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZAMIDE INHIBITOR
3BEAA:666-910CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH A PYRIMIDINOPYRIDONE INHIBITOR
3BEGA:134-144,A:168-655CRYSTAL STRUCTURE OF SR PROTEIN KINASE 1 COMPLEXED TO ITS SUBSTRATE ASF/SF2
3BELA:793-986X-RAY STRUCTURE OF EGFR IN COMPLEX WITH OXIME INHIBITOR
3BGPA:125-305HUMAN PIM-1 COMPLEXED WITH A BENZOISOXAZOLE INHIBITOR VX1
3BGQA:125-305HUMAN PIM-1 KINASE IN COMPLEX WITH AN TRIAZOLO PYRIDAZINE INHIBITOR VX2
3BGZA:125-305HUMAN PIM-1 KINASE IN COMPLEX WITH DIPHENYL INDOLE INHIBITOR VX3
3BHHC:93-300; A:93-301; B:93-301; D:93-301CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IIB ISOFORM 1 (CAMK2B)
3BHTC:85-294; A:85-295STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 3
3BHUC:85-294; A:85-295STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 5
3BHVC:85-294; A:85-295STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR VARIOLIN B
3BHYA:99-283CRYSTAL STRUCTURE OF HUMAN DEATH ASSOCIATED PROTEIN KINASE 3 (DAPK3) IN COMPLEX WITH A BETA-CARBOLINE LIGAND
3BI6A:356-360,A:380-570WEE1 KINASE COMPLEX WITH INHIBITOR PD352396
3BIZA:356-361,A:380-569WEE1 KINASE COMPLEX WITH INHIBITOR PD331618
3BKBA:643-821CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V-FES)
3BLHA:108-325CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1
3BLQA:108-325CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH ATP
3BLRA:108-326CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH FLAVOPIRIDOL
3BPRA:674-859; B:674-859; C:674-859; D:674-859CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR C52
3BQCA:7-24,A:116-330HIGH PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3BQRA:99-284CRYSTAL STRUCTURE OF HUMAN DEATH ASSOCIATED PROTEIN KINASE 3 (DAPK3) IN COMPLEX WITH AN IMIDAZO-PYRIDAZINE LIGAND
3BRBA:674-859; B:674-859CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH ADP
3BU3A:1079-1281CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE
3BU5A:1079-1281CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE AND ATP
3BU6A:1079-1281CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PHOSPHOPEPTIDE
3BV2A:111-319MORPHOLINO PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 30
3BV3A:111-319MORPHOLINO PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 2
3BWFA:125-305CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AN OSMIUM COMPOUND
3BX5A:111-319P38 ALPHA MAP KINASE COMPLEXED WITH BMS-640994
3BYMA:319-500X-RAY CO-CRYSTAL STRUCTURE AMINOBENZIMIDAZOLE TRIAZINE 1 BOUND TO LCK
3BYOA:319-500X-RAY CO-CRYSTAL STRUCTURE OF 2-AMINO-6-PHENYLPYRIMIDO[5', 4':5,6]PYRIMIDO[1,2-A]BENZIMIDAZOL-5(6H)-ONE 25 BOUND TO LCK
3BYSA:321-501CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE AMIDE 10B
3BYUA:321-501CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE REVERSE AMIDE 23
3BZ3A:502-684CRYSTAL STRUCTURE ANALYSIS OF FOCAL ADHESION KINASE WITH A METHANESULFONAMIDE DIAMINOPYRIMIDINE INHIBITOR
3C0GA:94-322; B:94-324CASK CAM-KINASE DOMAIN- 3'-AMP COMPLEX, P1 FORM
3C0HA:94-304; B:94-304CASK CAM-KINASE DOMAIN- AMPPNP COMPLEX, P1 FORM
3C0IA:94-303CASK CAM-KINASE DOMAIN- 3'-AMP COMPLEX, P212121 FORM
3C13A:7-24,A:116-330LOW PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3C1XA:1160-1357CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A PYRROLOTRIAZINE BASED INHIBITOR
3C4CA:534-722; B:534-722B-RAF KINASE IN COMPLEX WITH PLX4720
3C4D  [entry was replaced by entry 4FK3 without any CATH domain information]
3C4EA:125-305; B:125-305; C:125-305; D:125-305PIM-1 KINASE DOMAIN IN COMPLEX WITH 3-AMINOPHENYL-7-AZAINDOLE
3C4FA:564-759; B:564-759FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3-METHOXYBENZYL)-7-AZAINDOLE
3C5UA:111-319P38 ALPHA MAP KINASE COMPLEXED WITH A BENZOTHIAZOLE BASED INHIBITOR
3C7QA:919-1166STRUCTURE OF VEGFR2 KINASE DOMAIN IN COMPLEX WITH BIBF1120
3CBLA:643-821CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V-FES) IN COMPLEX WITH STAUROSPORINE AND A CONSENSUS PEPTIDE
3CC6A:505-687CRYSTAL STRUCTURE OF KINASE DOMAIN OF PROTEIN TYROSINE KINASE 2 BETA (PTK2B)
3CCNA:1160-1346X-RAY STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR.
3CD3A:643-821CRYSTAL STRUCTURE OF PHOSPHORYLATED HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V-FES) IN COMPLEX WITH STAUROSPORINE AND A CONSENSUS PEPTIDE
3CD8A:1160-1346X-RAY STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR.
3CE3A:1160-1357CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A PYRROLOPYRIDINEPYRIDONE BASED INHIBITOR
3CGFA:151-370IRAK-4 INHIBITORS (PART II)- A STRUCTURE BASED ASSESSMENT OF IMIDAZO[1,2 A]PYRIDINE BINDING
3CGOA:151-363IRAK-4 INHIBITORS (PART II)- A STRUCTURE BASED ASSESSMENT OF IMIDAZO[1,2 A]PYRIDINE BINDING
3CIKA:276-494HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS
3CJFA:917-1164CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 3,4,5-TRIMETHOXY ANILINE CONTAINING PYRIMIDINE
3CJGA:917-1164CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 3,4,5-TRIMETHOXY ANILINE CONTAINING PYRIMIDINE
3CKWA:87-283CRYSTAL STRUCTURE OF STERILE 20-LIKE KINASE 3 (MST3, STK24)
3CKXA:87-283CRYSTAL STRUCTURE OF STERILE 20-LIKE KINASE 3 (MST3, STK24) IN COMPLEX WITH STAUROSPORINE
3CLYA:1567-1762CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAINS TRAPPED IN TRANS-PHOSPHORYLATION REACTION
3COHA:217-387; B:217-387CRYSTAL STRUCTURE OF AURORA-A IN COMPLEX WITH A PENTACYCLIC INHIBITOR
3COIA:112-319CRYSTAL STRUCTURE OF P38DELTA KINASE
3COKA:95-265; B:95-265CRYSTAL STRUCTURE OF PLK4 KINASE
3COMB:105-300; A:105-298CRYSTAL STRUCTURE OF MST1 KINASE
3CP9A:919-1166; B:919-1165CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR
3CPBA:919-1166; B:919-1165CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BISAMIDE INHIBITOR
3CPCA:919-1166; B:919-1165CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR
3CQUA:234-428CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR
3CQWA:234-428CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR
3CS9A:318-500; B:318-498; C:318-497; D:318-500HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB
3CTHA:1160-1357CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A AMINOPYRIDINE BASED INHIBITOR
3CTJA:1160-1357CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A AMINOPYRIDINE BASED INHIBITOR
3D4QA:534-723; B:534-723PYRAZOLE-BASED INHIBITORS OF B-RAF KINASE
3D7TB:341-526; A:269-445STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
3D7ZA:111-319CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIPHENYL AMIDE INHIBITOR
3D94A:1052-1253CRYSTAL STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE IN COMPLEX WITH PQIP
3D9VA:160-358; B:160-358CRYSTAL STRUCTURE OF ROCK I BOUND TO H-1152P A DI-METHYLATED VARIANT OF FASUDIL
3DA6A:151-365CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH N-(3-METHYL-4-(3-(2-(METHYLAMINO)PYRIMIDIN-4-YL)PYRIDIN-2-YLOXY) NAPHTHALEN-1-YL)-1H-BENZO[D]IMIDAZOL-2-AMINE
3DDPA:85-295; C:85-295STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR CR8
3DDQA:85-295; C:85-294STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR ROSCOVITINE
3DFCB:106-291CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH AMPPNP
3DGKA:106-292CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN
3DKCA:1160-1362STRUCTURE OF MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH ATP
3DKFA:1160-1361STRUCTURE OF MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH INHIBITOR SGX-523
3DKGA:1160-1356STRUCTURE OF MUTANT(Y1248L) MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH INHIBITOR SGX-523
3DKOA:714-902COMPLEX BETWEEN THE KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7) AND INHIBITOR ALW-II-49-7
3DOGA:85-295; C:85-294STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR N-&-N1
3DPKA:666-910CFMS TYROSINE KINASE IN COMPLEX WITH A PYRIDOPYRIMIDINONE INHIBITOR
3DS6A:111-319; B:111-319; C:111-319; D:111-319P38 COMPLEX WITH A PHTHALAZINE INHIBITOR
3DT1A:111-319P38 COMPLEXED WITH A QUINAZOLINE INHIBITOR
3DTCA:225-405CRYSTAL STRUCTURE OF MIXED-LINEAGE KINASE MLK1 COMPLEXED WITH COMPOUND 16
3DTWA:919-1166; B:919-1166CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZISOXAZOLE INHIBITOR
3E3BX:8-25,X:117-334CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2ALPHA PRIME WITH A POTENT INDAZOLE-DERIVATIVE INHIBITOR
3E62A:932-1128FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
3E63A:932-1128FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
3E64A:932-1128FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
3E7OB:113-332; A:113-332CRYSTAL STRUCTURE OF JNK2
3E87A:236-429; B:236-429CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS
3E88A:236-429; B:236-429CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS
3E8DA:236-429; B:236-429CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS
3E92A:111-319CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIARYL AMIDE INHIBITOR
3E93A:111-319CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIARYL AMIDE INHIBITOR
3EFJA:1160-1351; B:1160-1351STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 7
3EFKA:1160-1351; B:1160-1351STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 50
3EFWB:217-387; A:217-387STRUCTURE OF AURORAA WITH PYRIDYL-PYRIMIDINE UREA INHIBITOR
3EH9A:106-291CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH ADP
3EHAA:106-291CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH AMPPNP
3EIDA:85-296; C:85-296CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
3EJ1A:85-296; C:85-296CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
3EKKA:1079-1282INSULIN RECEPTOR KINASE COMPLEXED WITH AN INHIBITOR
3EKNA:1079-1283INSULIN RECEPTOR KINASE COMPLEXED WITH AN INHIBITOR
3ELJA:113-332JNK1 COMPLEXED WITH A BIS-ANILINO-PYRROLOPYRIMIDINE INHIBITOR.
3EQBA:147-382X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
3EQPB:208-392; A:208-390CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T95
3EQRA:208-392; B:208-390CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T74
3ET7A:505-687CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-2318841
3ETAB:1079-1283; A:1079-1283KINASE DOMAIN OF INSULIN RECEPTOR COMPLEXED WITH A PYRROLO PYRIDINE INHIBITOR
3EYGA:959-1154CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
3EYHA:959-1154CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
3EZRA:85-296CDK-2 WITH INDAZOLE INHIBITOR 17 BOUND AT ITS ACTIVE SITE
3EZVA:85-296CDK-2 WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE
3F2AA:125-308CRYSTAL STRUCTURE OF HUMAN PIM-1 IN COMPLEX WITH DAPPA
3F5GA:106-291CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH ADP AND MG2+
3F5PC:1079-1279; E:1079-1279; F:1079-1279; G:1079-1279; A:1079-1279; H:1079-1279; B:1079-1279; D:1079-1279; M:1079-1279; I:1079-1279; R:1079-1279; S:1079-1279; T:1079-1279; J:1079-1279; K:1079-1279; L:1079-1279COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3-CYANOQUINOLINE INHIBITOR
3F5UA:106-291CRYSTAL STRUCTURE OF THE DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH AMPPNP AND MG2+
3F5XA:85-296; C:85-296CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE
3F66A:1160-1349; B:1160-1349HUMAN C-MET KINASE IN COMPLEX WITH QUINOXALINE INHIBITOR
3F7ZA:137-383; B:137-383X-RAY CO-CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3BETA IN COMPLEX WITH AN INHIBITOR
3F82A:1160-1357CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH N-(4-(2-AMINO-3-CHLOROPYRIDIN-4-YLOXY)-3-FLUOROPHENYL)-4-ETHOXY-1-(4-FLUOROPHENYL)-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE
3F88A:137-383; B:137-383GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR COMPLEX
3FC2A:137-309PLK1 IN COMPLEX WITH BI6727
3FDNA:217-394STRUCTURE-BASED DRUG DESIGN OF NOVEL AURORA KINASE A INHIBITORS: STRUCTURE BASIS FOR POTENCY AND SPECIFICITY
3FE3A:135-324; B:135-324CRYSTAL STRUCTURE OF THE KINASE MARK3/PAR-1: T211A-S215A DOUBLE MUTANT
3FHRA:121-349HIGH RESOLUTION CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3 (MK3)-INHIBITOR COMPLEX
3FI2A:151-503CRYSTAL STRUCTURE OF JNK3 WITH AMINO-PYRAZOLE INHIBITOR, SR-3451
3FI3A:151-377CRYSTAL STRUCTURE OF JNK3 WITH INDAZOLE INHIBITOR, SR-3737
3FI4A:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO4499
3FKLA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO9552
3FKNA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO7125
3FKOA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO3668
3FL4A:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO5634
3FLNC:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH R1487
3FLQA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-((S)-2-METHANESULFONYL-1-METHYL-ETHYLAMINO)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN
3FLSA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-((R)-2-METHANESULFONYL-1-METHYL-ETHYLAMINO)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FLWA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH PAMAPIMOD
3FLYA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-ISOPROPYLAMINO-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FLZA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 8-METHYL-6-PHENOXY-2-(TETRAHYDRO-PYRAN-4-YLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FMEA:133-333CRYSTAL STRUCTURE OF HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 6 (MEK6) ACTIVATED MUTANT (S207D, T211D)
3FMHA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-8-METHYL-2-((R)-1-METHYL-2-TETRAZOL-2-YL-ETHYLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FMJA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 4-(5-METHYL-3-PHENYL-ISOXAZOL-4-YL)-PYRIMIDIN-2-YLAMINE
3FMKA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-8-METHYL-2-((S)-1-METHYL-2-TETRAZOL-2-YL-ETHYLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FMLA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6224
3FMMA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6226
3FMNA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO2530
3FPMA:141-342CRYSTAL STRUCTURE OF A SQUARATE INHIBITOR BOUND TO MAPKAP KINASE-2
3FQEA:451-639CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH YM193306
3FQHA:451-634; B:451-633CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH A 2-SUBSTITUTED 7-AZAINDOLE
3FQSA:451-639CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH R406
3FSFA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 3-(2,6-DICHLORO-PHENYL)-7-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-1-METHYL-3,4-DIHYDRO-1H-PYRIMIDO[4,5-D]PYRIMIDIN-2-ONE
3FSKA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6257
3FUPA:932-1128; B:932-1128CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
3FV8A:151-702JNK3 BOUND TO PIPERAZINE AMIDE INHIBITOR, SR2774.
3FWQA:7-24,A:116-331; B:7-24,B:116-331INACTIVE CONFORMATION OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT
3FXWA:121-349HIGH RESOLUTION CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3/INHIBITOR 2 COMPLEX
3FXXA:703-904HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BOUND TO SUBSTRATE KQWDNYE[PTYR]IW
3FY2A:704-904HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BOUND TO SUBSTRATE KQWDNYEFIW
3FYJX:141-364CRYSTAL STRUCTURE OF AN OPTIMZIED BENZOTHIOPHENE INHIBITOR BOUND TO MAPKAP KINASE-2 (MK-2)
3FYKX:141-364CRYSTAL STRUCTURE OF A BENZTHIOPHENE LEAD BOUND TO MAPKAP KINASE-2 (MK-2)
3FZ1A:85-296CRYSTAL STRUCTURE OF A BENZTHIOPHENE INHIBITOR BOUND TO HUMAN CYCLIN-DEPENDENT KINASE-2 (CDK-2)
3FZOA:505-687CRYSTAL STRUCTURE OF PYK2-APO, PROLINE-RICH TYROSINE KINASE
3FZPA:505-687CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH ATPGS
3FZRA:505-687CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-431396
3FZSA:505-687CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH BIRB796
3FZTA:505-687CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-4618433
3G0EA:673-931KIT KINASE DOMAIN IN COMPLEX WITH SUNITINIB
3G0FA:673-924; B:673-924KIT KINASE DOMAIN MUTANT D816H IN COMPLEX WITH SUNITINIB
3G2FB:284-513; A:284-510CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE II (BMPR2) AT 2.35 A RESOLUTION
3G33A:103-299; C:103-299CRYSTAL STRUCTURE OF CDK4/CYCLIN D3
3G90X:151-370JNK-3 BOUND TO (Z)-5-FLUORO-1-((6-FLUORO-4H-BENZO[D][1,3]DIOXIN-8-YL) METHYL)-3-(HYDROXYIMINO)INDOLIN-2-ONE
3G9LX:151-370JNK3 BOUND TO (Z)-1-((6-FLUORO-4H-BENZO[D][1,3]DIOXIN-8-YL)METHYL)-3-(HYDROXYIMINO)-4-STYRYLINDOLIN-2-ONE
3G9NA:107-326JNK3 BOUND TO (Z)-1-((6-FLUORO-4H-BENZO[D][1,3]DIOXIN-8-YL)METHYL)-3-(HYDROXYIMINO)-4-PHENYLINDOLIN-2-ONE
3GB2A:137-383GSK3BETA INHIBITOR COMPLEX
3GC7A:111-319THE STRUCTURE OF P38ALPHA IN COMPLEX WITH A DIHYDROQUINAZOLINONE
3GC8A:111-319; B:111-319THE STRUCTURE OF P38BETA C162S IN COMPLEX WITH A DIHYDROQUINAZOLINONE
3GC9A:111-319; B:111-319THE STRUCTURE OF P38BETA C119S, C162S IN COMPLEX WITH A DIHYDROQUINAZOLINONE INHIBITOR
3GCPA:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH SB203580
3GCQA:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH RL45
3GCSA:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH SORAFENIB
3GCUB:111-319; A:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH RL48
3GCVA:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH RL62
3GENA:477-658THE 1.6 A CRYSTAL STRUCTURE OF HUMAN BRUTON'S TYROSINE KINASE BOUND TO A PYRROLOPYRIMIDINE-CONTAINING COMPOUND
3GFEA:111-319CRYSTAL STRUCTURE OF P38A MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH A PYRAZOLOPYRIDINONE INHIBITOR
3GI3A:111-319CRYSTAL STRUCTURE OF A N-PHENYL-N'-NAPHTHYLUREA ANALOG IN COMPLEX WITH P38 MAP KINASE
3GOKB:141-342; E:141-342; H:141-342; K:141-342; G:141-342; A:141-342; C:141-342; F:141-342; I:141-342; L:141-342; D:141-342; J:141-342BINDING SITE MAPPING OF PROTEIN LIGANDS
3GP0A:111-319CRYSTAL STRUCTURE OF HUMAN MITOGEN ACTIVATED PROTEIN KINASE 11 (P38 BETA) IN COMPLEX WITH NILOTINIB
3GQIA:564-759CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
3GQLA:564-759; B:564-759; C:564-759CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
3GXLA:85-298ALK-5 KINASE COMPLEX WITH GW857175
3H0YA:217-387AURORA A IN COMPLEX WITH A BISANILINOPYRIMIDINE
3H0ZA:217-387; B:217-387; C:217-387AURORA A IN COMPLEX WITH A BISANILINOPYRIMIDINE
3H10A:217-387; B:217-387; D:217-387AURORA A INHIBITOR COMPLEX
3H30A:7-24,A:116-334; B:7-24,B:116-334CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 WITH 5,6-DICHLORO-1-BETA-D-RIBOFURANOSYLBENZIMIDAZOLE
3H9OA:166-357PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK-1) IN COMPLEX WITH COMPOUND 9
3H9RA:288-499CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TYPE I ACTIVIN RECEPTOR (ACVR1) IN COMPLEX WITH FKBP12 AND DORSOMORPHIN
3HA6A:217-387CRYSTAL STRUCTURE OF AURORA A IN COMPLEX WITH TPX2 AND COMPOUND 10
3HA8A:111-319THE COMPLEX STRUCTURE OF THE MAP KINASE P38/COMPOUND 14B
3HDMA:183-372CRYSTAL STRUCTURE OF SERUM AND GLUCOCORTICOID-REGULATED KINASE 1 IN COMPLEX WITH COMPOUND 1
3HDNA:183-372CRYSTAL STRUCTURE OF SERUM AND GLUCOCORTICOID-REGULATED KINASE 1 IN COMPLEX WITH COMPOUND 2
3HECA:111-319P38 IN COMPLEX WITH IMATINIB
3HEGA:111-319P38 IN COMPLEX WITH SORAFENIB
3HL7A:110-318CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH SD-0006
3HLLA:111-319CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH PH-797804
3HMMA:85-298STRUCTURE OF ALK5 + GW855857
3HNGA:912-1158CRYSTAL STRUCTURE OF VEGFR1 IN COMPLEX WITH N-(4-CHLOROPHENYL)-2-((PYRIDIN-4-YLMETHYL)AMINO)BENZAMIDE
3HP2A:111-319CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A PYRIDINONE COMPOUND
3HP5A:111-319CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A PYRIMIDOPYRIDAZINONE COMPOUND
3HRBA:111-319P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3HRCA:166-357CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ATP
3HUBA:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH SCIOS-469
3HUCA:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH RL40
3HV3A:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH RL49
3HV4A:111-319; B:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH RL51
3HV5A:111-319; B:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH RL24
3HV6A:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH RL39
3HV7A:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH RL38
3HVCA:111-319CRYSTAL STRUCTURE OF HUMAN P38ALPHA MAP KINASE
3I4BA:137-382; B:137-382CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH A PYRIMIDYLPYRROLE INHIBITOR
3I5NA:1160-1346CRYSTAL STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR 13
3I5ZA:106-336CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-N-(2-HYDROXY-1-PHENYLETHYL)-4-(5-METHYL-2-(PHENYLAMINO)PYRIMIDIN-4-YL)-1H-PYRROLE-2-CARBOXAMIDE
3I60A:106-336CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-4-(2-(2-CHLOROPHENYLAMINO)-5-METHYLPYRIMIDIN-4-YL)-N-(2-HYDROXY-1-PHENYLETHYL)-1H-PYRROLE-2-CARBOXAMIDE
3I81A:1049-1249CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH BMS-754807 [1-(4-((5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO)PYRROLO[2,1-F][1,2,4]TRIAZIN-2-YL)-N-(6-FLUORO-3-PYRIDINYL)-2-METHYL-L-PROLINAMIDE]
3IDPB:534-720; A:534-720B-RAF V600E KINASE DOMAIN IN COMPLEX WITH AN AMINOISOQUINOLINE INHIBITOR
3IG7A:85-296NOVEL CDK-5 INHIBITORS - CRYSTAL STRUCTURE OF INHIBITOR EFP WITH CDK-2
3IGGA:85-296NOVEL CDK-5 INHIBITORS - CRYSTAL STRUCTURE OF INHIBITOR EFQ WITH CDK-2
3II5A:533-719; B:533-720THE COMPLEX OF WILD-TYPE B-RAF WITH PYRAZOLO PYRIMIDINE INHIBITOR
3IO7A:932-11282-AMINOPYRAZOLO[1,5-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2
3IOKA:932-11282-AMINOPYRAZOLO[1,5-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2
3IONA:166-357PDK1 IN COMPLEX WITH COMPOUND 8H
3IOPA:166-357PDK-1 IN COMPLEX WITH THE INHIBITOR COMPOUND-8I
3IPHA:111-319CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH A BIPHENYLAMIDE INHIBITOR
3ITZA:111-319CRYSTAL STRUCTURE OF P38A MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH A PYRAZOLOPYRIDAZINE INHIBITOR
3IW4A:424-617; C:424-617; B:424-617CRYSTAL STRUCTURE OF PKC ALPHA IN COMPLEX WITH NVP-AEB071
3IW5A:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH AN INDOLE DERIVATIVE
3IW6A:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH A BENZYLPIPERAZIN-PYRROL
3IW7A:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH AN IMIDAZO-PYRIDINE
3IW8A:111-319STRUCTURE OF INACTIVE HUMAN P38 MAP KINASE IN COMPLEX WITH A THIAZOLE-UREA
3JPVA:125-305CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A PYRROLO[2,3-A]CARBAZOLE LIGAND
3JS2A:564-759; B:564-759CRYSTAL STRUCTURE OF MINIMAL KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH 5-(2-THIENYL) NICOTINIC ACID
3JUHA:7-24,A:116-331; B:7-24,B:116-331CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PROTEIN KINASE CK2ALPHA WITH ALTERED COSUBSTRATE SPECIFICITY
3JXWA:125-306DISCOVERY OF 3H-BENZO[4,5]THIENO[3,2-D]PYRIMIDIN-4-ONES AS POTENT, HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
3JY0A:125-307DISCOVERY OF 3H-BENZO[4,5]THIENO[3,2-D]PYRIMIDIN-4-ONES AS POTENT, HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
3JY9A:932-1128JANUS KINASE 2 INHIBITORS
3JYAA:125-306DISCOVERY OF 3H-BENZO[4,5]THIENO[3,2-D]PYRIMIDIN-4-ONES AS POTENT, HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
3K3IA:111-319P38ALPHA BOUND TO NOVEL DGF-OUT COMPOUND PF-00215955
3K3JA:111-319P38ALPHA BOUND TO NOVEL DFG-OUT COMPOUND PF-00416121
3KA0A:141-364MK2 COMPLEX WITH INHIBITOR 6-(5-(2-AMINOPYRIMIDIN-4-YLAMINO)-2-HYDROXYPHENYL)-N-METHYLBENZO[B]THIOPHENE-2-CARBOXAMIDE
3KB7A:137-309CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
3KC3F:141-342; E:141-342; B:141-342; L:141-342; A:141-342; H:141-342; I:141-342; J:141-342; K:141-342; C:141-342; G:141-342; D:141-342MK2 COMPLEXED TO INHIBITOR N4-(7-(BENZOFURAN-2-YL)-1H-INDAZOL-5-YL) PYRIMIDINE-2,4-DIAMINE
3KCFB:285-501; A:285-500; C:285-500; D:285-500; E:285-500CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR
3KCKA:932-1128A NOVEL CHEMOTYPE OF KINASE INHIBITORS
3KF7A:111-319CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A TRIAZOLOPYRIMIDINE COMPOUND
3KGAA:141-364CRYSTAL STRUCTURE OF MAPKAP KINASE 2 (MK2) COMPLEXED WITH A POTENT 3-AMINOPYRAZOLE ATP SITE INHIBITOR
3KN5A:462-482,A:501-729; B:462-482,B:501-729CRYSTAL STRUCTURE OF THE C-TERMINAL KINASE DOMAIN OF MSK1 IN COMPLEX WITH AMP-PNP
3KN6A:462-482,A:501-729; B:462-482,B:501-729CRYSTAL STRUCTURE OF THE C-TERMINAL KINASE DOMAIN OF MSK1
3KQ7A:111-319STRUCTURE OF HUMAN P38ALPHA WITH N-[4-METHYL-3-(6-{[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]AMINO}PYRIDINE-3-AMIDO)PHENYL]-2-(MORPHOLIN-4-YL)PYRIDINE-4-CARBOXAMIDE
3KRWA:276-494HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (SOAK)
3KRXA:276-494HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (CO-CRYSTAL)
3KULB:716-899; A:716-900KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 8 (EPHA8)
3KVXA:151-366JNK3 BOUND TO AMINOPYRIMIDINE INHIBITOR, SR-3562
3KXXA:564-759; B:564-759; C:564-759; D:564-759STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1
3KY2A:564-759; B:564-759CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN
3L1SB:137-382; A:137-3823-ARYL-4-(ARYLHYDRAZONO)-1H-PYRAZOL-5-ONES: HIGHLY LIGAND EFFICIENT AND POTENT INHIBITORS OF GSK3
3L8SA:111-319HUMAN P38 MAP KINASE IN COMPLEX WITH CP-547632
3L8VA:1160-1357CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A BIARYLAMINE BASED INHIBITOR
3L8XA:111-319P38 ALPHA KINASE COMPLEXED WITH A PYRAZOLO-PYRIMIDINE BASED INHIBITOR
3LAUA:217-387CRYSTAL STRUCTURE OF AURORA2 KINASE IN COMPLEX WITH A GSK3BETA INHIBITOR
3LB7  [entry was replaced by entry 3OMV without any CATH domain information]
3LCDA:666-910INHIBITOR BOUND TO A DFG-IN STRUCTURE OF THE KINASE DOMAIN OF CSF-1R
3LCKA:319-500THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK), ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394)
3LFNA:85-296CRYSTAL STRUCTURE OF CDK2 WITH SAR57, AN AMINOINDAZOLE TYPE INHIBITOR
3LFQA:85-296CRYSTAL STRUCTURE OF CDK2 WITH SAR60, AN AMINOINDAZOLE TYPE INHIBITOR
3LFSA:85-296CRYSTAL STRUCTURE OF CDK2 WITH SAR37, AN AMINOINDAZOLE TYPE INHIBITOR
(-)
Human (homo sapiens) (1)
1FGKA:564-759; B:564-757CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1
(-)
Leishmania major. Organism_taxid: 5664. (1)
3E3PA:105-353; B:105-353GLYCOGEN SYNTHASE KINASE FROM LEISHMANIA MAJOR
(-)
Leopard danio,zebra danio,zebra fish (Danio rerio) (4)
3D5UA:123-295CRYSTAL STRUCTURE OF A WILDTYPE POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN.
3D5VA:120-312CRYSTAL STRUCTURE OF AN ACTIVATED (THR->ASP) POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN.
3D5WA:123-295CRYSTAL STRUCTURE OF A PHOSPHORYLATED POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH ADP.
3D5XA:123-295CRYSTAL STRUCTURE OF AN ACTIVATED (THR->ASP) POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH WORTMANNIN.
(-)
Maize (Zea mays) (1)
3BE9A:6-24,A:116-333STRUCTURE-BASED DESIGN AND SYNTHESIS OF NOVEL MACROCYCLIC PYRAZOLO[1,5-A] [1,3,5]TRIAZINE COMPOUNDS AS POTENT INHIBITORS OF PROTEIN KINASE CK2 AND THEIR ANTICANCER ACTIVITIES
(-)
Man (Homo sapiens) (1)
3CTQA:111-319STRUCTURE OF MAP KINASE P38 IN COMPLEX WITH A 1-O-TOLYL-1,2, 3-TRIAZOLE-4-CARBOXAMIDE
(-)
Mouse (Mus musculus) (21)
2PUUA:111-319CRYSTAL STRUCTURE OF P38 COMPLEX WITH 1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(6-MORPHOLIN-4-YLMETHYL-PYRIDIN-3-YL)NAPHTHALEN-1-YL]UREA
2ZV7A:322-501LYN TYROSINE KINASE DOMAIN, APO FORM
2ZV8A:322-501LYN TYROSINE KINASE DOMAIN-AMP-PNP COMPLEX
2ZV9A:322-501LYN TYROSINE KINASE DOMAIN-PP2 COMPLEX
2ZVAA:322-502LYN TYROSINE KINASE DOMAIN-DASATINIB COMPLEX
3D14A:230-400CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH 1-{5-[2-(THIENO[3,2-D]PYRIMIDIN-4-YLAMINO)-ETHYL]- THIAZOL-2-YL}-3-(3-TRIFLUOROMETHYL-PHENYL)-UREA
3D15A:230-400CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH 1-(3-CHLORO-PHENYL)-3-{5-[2-(THIENO[3,2-D]PYRIMIDIN-4-YLAMINO)- ETHYL]-THIAZOL-2-YL}-UREA [SNS-314]
3D2IA:230-400CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH 1-{5-[2-(1-METHYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-7-YLAMINO)-ETHYL]-THIAZOL-2-YL}-3-(3-TRIFLUOROMETHYL-PHENYL)-UREA
3D2KA:230-400CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH [7-(2-{2-[3-(3-CHLORO-PHENYL)-UREIDO]-THIAZOL-5-YL}-ETHYLAMINO)-PYRAZOLO[4,3-D]PYRIMIDIN-1-YL]-ACETIC ACID
3DAJA:217-387CRYSTAL STRUCTURE OF AURORA A COMPLEXED WITH AN INHIBITOR DISCOVERED THROUGH SITE-DIRECTED DYNAMIC TETHERING
3DJ5A:230-400CRYSTAL STRUCTURE OF THE MOUSE AURORA-A CATALYTIC DOMAIN (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH COMPOUND 290.
3DJ6A:230-400CRYSTAL STRUCTURE OF THE MOUSE AURORA-A CATALYTIC DOMAIN (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH COMPOUND 823.
3DJ7A:230-400CRYSTAL STRUCTURE OF THE MOUSE AURORA-A CATALYTIC DOMAIN (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH COMPOUND 130.
3DK3B:318-505; A:318-502CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
3DK6B:318-505; A:318-502CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
3DK7B:318-505; A:318-502CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
3FHIA:13-32,A:127-317CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE CATALYTIC AND REGULATORY (RI{ALPHA}) SUBUNITS OF PKA
3FJQE:15-32,E:127-317CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA IN COMPLEX WITH PEPTIDE INHIBITOR PKI ALPHA (6-25)
3G51A:151-346STRUCTURAL DIVERSITY OF THE ACTIVE CONFORMATION OF THE N-TERMINAL KINASE DOMAIN OF P90 RIBOSOMAL S6 KINASE 2
3IDBA:8-32,A:127-317CRYSTAL STRUCTURE OF (108-268)RIIB:C HOLOENZYME OF CAMP-DEPENDENT PROTEIN KINASE
3IDCA:8-32,A:127-317CRYSTAL STRUCTURE OF (102-265)RIIB:C HOLOENZYME OF CAMP-DEPENDENT PROTEIN KINASE
(-)
Mus musculus. Organism_taxid: 10090. (1)
2QURA:11-32,A:127-317CRYSTAL STRUCTURE OF F327A/K285P MUTANT OF CAMP-DEPENDENT PROTEIN KINASE
(-)
Mycobacterium tuberculosis h37rv. Organism_taxid: 83332. Strain: h37rv. (2)
2FUMA:96-277; B:96-278; D:96-277; C:96-278CATALYTIC DOMAIN OF PROTEIN KINASE PKNB FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MITOXANTRONE
2H34A:97-276; B:97-276APOENZYME CRYSTAL STRUCTURE OF THE TUBERCULOSIS SERINE/THREONINE KINASE, PKNE
(-)
Mycobacterium tuberculosis. Organism_taxid: 1773. (1)
1MRUA:96-285; B:96-285INTRACELLULAR SER/THR PROTEIN KINASE DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKNB.
(-)
Mycobacterium tuberculosis. Organism_taxid: 1773. Strain: h37rv. (2)
3F61A:96-285CRYSTAL STRUCTURE OF M. TUBERCULOSIS PKNB LEU33ASP/VAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
3F69B:96-285; A:96-285CRYSTAL STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS PKNB MUTANT KINASE DOMAIN IN COMPLEX WITH KT5720
(-)
Mycobacterium tuberculosis. Organism_taxid: 83332. Strain: h37rv. (1)
1O6YA:96-278CATALYTIC DOMAIN OF PKNB KINASE FROM MYCOBACTERIUM TUBERCULOSIS
(-)
Norway rat (Rattus norvegicus) (19)
1A06A:98-276CALMODULIN-DEPENDENT PROTEIN KINASE FROM RAT
1CKIB:89-297; A:89-301RECOMBINANT CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1-317
1CKJB:89-298; A:89-301CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1-317 COMPLEX WITH BOUND TUNGSTATE
1ERKA:106-334STRUCTURE OF SIGNAL-REGULATED KINASE
1GOLA:106-334COORDINATES OF RAT MAP KINASE ERK2 WITH AN ARGININE MUTATION AT POSITION 52
1K9AF:273-450; D:273-443; E:273-443; A:273-443; B:273-443; C:273-443CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
1LUFA:657-858CRYSTAL STRUCTURE OF THE MUSK TYROSINE KINASE: INSIGHTS INTO RECEPTOR AUTOREGULATION
1U5QA:108-320; B:108-320CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K
1U5RA:108-320; B:108-320CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K
1Y8GA:132-321; B:132-321CATALYTIC AND UBIQUTIN-ASSOCIATED DOMAINS OF MARK2/PAR-1: INACTIVE DOUBLE MUTANT WITH SELENOMETHIONINE
1ZMUA:132-321; B:132-321CATALYTIC AND UBIQUTIN-ASSOCIATED DOMAINS OF MARK2/PAR-1: WILD TYPE
1ZMVA:132-321; B:132-321CATALYTIC AND UBIQUTIN-ASSOCIATED DOMAINS OF MARK2/PAR-1: K82R MUTANT
1ZMWA:132-321; B:132-321CATALYTIC AND UBIQUTIN-ASSOCIATED DOMAINS OF MARK2/PAR-1: T208A/S212A INACTIVE DOUBLE MUTANT
2ERKA:106-334PHOSPHORYLATED MAP KINASE ERK2
2FYSB:106-334; A:106-334CRYSTAL STRUCTURE OF ERK2 COMPLEX WITH KIM PEPTIDE DERIVED FROM MKP3
2GCDA:108-320; B:108-320TAO2 KINASE DOMAIN-STAUROSPORINE STRUCTURE
2GPHA:106-334DOCKING MOTIF INTERACTIONS IN THE MAP KINASE ERK2
3ERKA:106-334THE COMPLEX STRUCTURE OF THE MAP KINASE ERK2/SB220025
4ERKA:106-334THE COMPLEX STRUCTURE OF THE MAP KINASE ERK2/OLOMOUCINE
(-)
Pig (Sus scrofa) (3)
1CDKA:10-32,A:127-317; B:10-32,B:127-317CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (E.C.2.7.1.37) (PROTEIN KINASE A) COMPLEXED WITH PROTEIN KINASE INHIBITOR PEPTIDE FRAGMENT 5-24 (PKI(5-24) ISOELECTRIC VARIANT CA) AND MN2+ ADENYLYL IMIDODIPHOSPHATE (MNAMP-PNP) AT PH 5.6 AND 7C AND 4C
1CMKE:10-32,E:127-317CRYSTAL STRUCTURES OF THE MYRISTYLATED CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE REVEAL OPEN AND CLOSED CONFORMATIONS
1CTPE:10-32,E:127-317STRUCTURE OF THE MAMMALIAN CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE AND AN INHIBITOR PEPTIDE DISPLAYS AN OPEN CONFORMATION
(-)
Plasmodium falciparum. Organism_taxid: 5833. (4)
1OB3A:84-286; B:84-286STRUCTURE OF P. FALCIPARUM PFPK5
1V0BB:84-287; A:84-287CRYSTAL STRUCTURE OF THE T198A MUTANT OF PFPK5
1V0OA:84-287; B:84-287STRUCTURE OF P. FALCIPARUM PFPK5-INDIRUBIN-5-SULPHONATE LIGAND COMPLEX
1V0PA:82-286; B:84-286STRUCTURE OF P. FALCIPARUM PFPK5-PURVALANOL B LIGAND COMPLEX
(-)
Pseudomonas syringae. Organism_taxid: 317. (1)
2QKWB:119-317STRUCTURAL BASIS FOR ACTIVATION OF PLANT IMMUNITY BY BACTERIAL EFFECTOR PROTEIN AVRPTO
(-)
Rabbit (Oryctolagus cuniculus) (3)
1PHKA:106-291TWO STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHORYLASE, KINASE: AN ACTIVE PROTEIN KINASE COMPLEXED WITH NUCLEOTIDE, SUBSTRATE-ANALOGUE AND PRODUCT
1QL6A:106-291THE CATALYTIC MECHANISM OF PHOSPHORYLASE KINASE PROBED BY MUTATIONAL STUDIES
2PHKA:106-290THE CRYSTAL STRUCTURE OF A PHOSPHORYLASE KINASE PEPTIDE SUBSTRATE COMPLEX: KINASE SUBSTRATE RECOGNITION
(-)
Rat (Rattus norvegicus) (4)
2R7IA:7-24,A:116-330; B:7-24,B:116-330; C:7-24,C:116-330; D:7-24,D:116-330CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
2WZJA:132-321; B:132-321; C:132-321; D:132-321; E:132-321; F:132-321CATALYTIC AND UBA DOMAIN OF KINASE MARK2/(PAR-1) K82R, T208E DOUBLE MUTANT
2Z7LA:108-338UNPHOSPHORYLATED MITOGEN ACTIVATED PROTEIN KINASE ERK2 IN COMPLEX WITH (4-{[5-CARBAMOYL-4-(3-METHYLANILINO)PYRIMIDIN 2-YL]AMINO}PHENYL)ACETIC ACID
3C9WA:106-334; B:106-334CRYSTAL STRUCTURE OF ERK-2 WITH HYPOTHEMYCIN COVALENTLY BOUND
(-)
Rattus norvegicus. Organism_taxid: 10116. (1)
2R0IA:132-321; B:132-321CRYSTAL STRUCTURE OF A KINASE MARK2/PAR-1 MUTANT
(-)
Toxoplasma gondii. Organism_taxid: 383379. Strain: rh. (1)
2W1ZA:194-216,A:360-556; B:194-216,B:360-557ROP2 FROM TOXOPLASMA GONDII: A VIRULENCE FACTOR WITH A PROTEIN-KINASE FOLD AND NO ENZYMATIC ACTIVITY.
(-)
Toxoplasma gondii. Organism_taxid: 5811. (3)
3BYVA:208-231,A:373-568CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPECIFIC RHOPTRY ANTIGEN KINASE DOMAIN
3DXNA:106-287CRYSTAL STRUCTURE OF THE CALCIUM-DEPENDENT KINASE FROM TOXOPLASMA GONDII, 541.M00134, KINASE DOMAIN.
3DZOA:190-222,A:364-559CRYSTAL STRUCTURE OF A RHOPTRY KINASE FROM TOXOPLASMA GONDII
(-)
Xenopus laevis. Organism_taxid: 8355. (2)
2BFXA:174-347; B:177-346MECHANISM OF AURORA-B ACTIVATION BY INCENP AND INHIBITION BY HESPERADIN.
2BFYA:174-347; B:177-346COMPLEX OF AURORA-B WITH INCENP AND HESPERADIN.
(-)
Zea mays. Organism_taxid: 4577 (1)
1OM1A:7-24,A:116-331CRYSTAL STRUCTURE OF MAIZE CK2 ALPHA IN COMPLEX WITH IQA
(-)
Zea mays. Organism_taxid: 4577. (14)
1ZOEA:7-24,A:116-331CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB-DERIVATIVES INHIBITORS
1ZOGA:7-24,A:116-331CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB-DERIVATIVES
1ZOHA:6-24,A:116-331CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB-DERIVATIVES INHIBITORS
2OXDA:7-24,A:116-331PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE K17, K22 AND K32 INHIBITORS
2OXXA:7-24,A:116-331PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE DERIVATIVES K17, K22 AND K32
2OXYA:7-24,A:116-333; B:7-24,B:116-333PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE DERIVATIVES K17, K22 AND K32
2PVHA:6-24,A:116-333STRUCTURE-BASED DESIGN OF PYRAZOLO[1,5-A][1,3,5]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2PVJA:6-24,A:116-332STRUCTURE-BASED DESIGN OF PYRAZOLO[1,5-A][1,3,5]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2PVKA:6-24,A:116-333STRUCTURE-BASED DESIGN OF PYRAZOLO[1,5-A][1,3,5]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2PVLA:6-24,A:116-333STRUCTURE-BASED DESIGN OF PYRAZOLO[1,5-A][1,3,5]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2PVMA:6-24,A:116-333STRUCTURE-BASED DESIGN OF PYRAZOLO[1,5-A][1,3,5]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2PVNA:6-24,A:116-333STRUCTURE-BASED DESIGN OF PYRAZOLO[1,5-A][1,3,5]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2QC6A:7-24,A:116-333PROTEIN KINASE CK2 IN COMPLEX WITH DBC
3FL5A:7-24,A:116-331PROTEIN KINASE CK2 IN COMPLEX WITH THE INHIBITOR QUINALIZARIN
(-)
Zea mays. Organism_taxid: 4577. (12)
1DAWA:7-24,A:116-333CRYSTAL STRUCTURE OF A BINARY COMPLEX OF PROTEIN KINASE CK2 (ALPHA-SUBUNIT) AND MG-AMPPNP
1DAYA:7-24,A:116-333CRYSTAL STRUCTURE OF A BINARY COMPLEX OF PROTEIN KINASE CK2 (ALPHA-SUBUNIT) AND MG-GMPPNP
1DS5A:7-24,A:116-333; B:7-24,B:116-333; C:7-24,C:116-333; D:7-24,D:116-333DIMERIC CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT IN COMPLEX WITH TWO BETA PEPTIDES MIMICKING THE ARCHITECTURE OF THE TETRAMERIC PROTEIN KINASE CK2 HOLOENZYME.
1F0QA:7-24,A:116-333CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT OF PROTEIN KINASE CK2 IN COMPLEX WITH THE NUCLEOTIDE COMPETITIVE INHIBITOR EMODIN
1J91A:7-24,A:116-333; B:7-24,B:116-333CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,5,6,7-TETRABROMOBENZOTRIAZOLE
1JAMA:7-24,A:116-333CRYSTAL STRUCTURE OF APO-FORM OF Z. MAYS CK2 PROTEIN KINASE ALPHA SUBUNIT
1LP4A:7-24,A:116-333CRYSTAL STRUCTURE OF A BINARY COMPLEX OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 WITH MG-AMPPNP
1LPUA:7-24,A:116-333LOW TEMPERATURE CRYSTAL STRUCTURE OF THE APO-FORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM ZEA MAYS
1LR4A:7-24,A:116-333ROOM TEMPERATURE CRYSTAL STRUCTURE OF THE APO-FORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM ZEA MAYS
1M2PA:7-24,A:116-331CRYSTAL STRUCTURE OF 1,8-DI-HYDROXY-4-NITRO-ANTHRAQUINONE/CK2 KINASE COMPLEX
1M2QA:7-24,A:116-333CRYSTAL STRUCTURE OF 1,8-DI-HYDROXY-4-NITRO-XANTEN-9-ONE/CK2 KINASE COMPLEX
1M2RA:7-24,A:116-333CRYSTAL STRUCTURE OF 5,8-DI-AMINO-1,4-DI-HYDROXY-ANTHRAQUINONE/CK2 KINASE COMPLEX
(-)
Zebra fish (Danio rerio) (2)
3DB6A:123-295CRYSTAL STRUCTURE OF AN ACTIVATED (THR->ASP) POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND 902
3DB8A:120-310CRYSTAL STRUCTURE OF AN ACTIVATED (THR->ASP) POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND 041
(-)
Zebrafish (Danio rerio) (4)
3DBCA:120-310CRYSTAL STRUCTURE OF AN ACTIVATED (THR->ASP) POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND 257
3DBDA:120-310CRYSTAL STRUCTURE OF AN ACTIVATED (THR->ASP) POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND 094
3DBEA:123-295CRYSTAL STRUCTURE OF AN ACTIVATED (THR->ASP) POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND 557
3DBFA:120-310CRYSTAL STRUCTURE OF AN ACTIVATED (THR->ASP) POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND 562